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Abstract 
 
Objectives: This systematic review describes the literature focussing on psychosocial 
functioning and health related quality of life (HRQOL) in young people with inflammatory 
bowel disease (IBD). It aims to critique the methodological quality of the identified studies, 
discuss the implications of their findings and make recommendations for future research. The 
following question was posed: what impact does IBD have on psychosocial functioning and 
HRQOL in children and adolescents? 
Methods: A systematic search strategy was used to identify relevant articles which were 
subject to strict inclusion and exclusion criteria. Identified papers were rated for 
methodological quality and data was extracted. 
Results: A total of 12 articles with ‗acceptable‘ or ‗good‘ quality rating scores were included 
in the review. After describing the demographic and methodological aspects of the studies, 
five main outcomes: self-esteem, HRQOL, anxiety and depression, social competence and 
behavioural functioning were examined.  
Conclusions: Due to the conflicting results and methodological limitations of the research in 
this field, only tentative conclusions could be drawn. Young people with IBD appear to have 
reduced HRQOL and an increased risk of developing psychiatric conditions compared to 
their healthy peers. The evidence for lowered self-esteem, self-reported symptoms of 
depression and anxiety, impaired social competence and behavioural problems was mixed. 
Methodological limitations are discussed and the implications of the review for future 
research and clinical practice outlined.  
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Introduction 
What is IBD? 
Inflammatory bowel disease (IBD), comprising Crohn‘s disease (CD), ulcerative colitis (UC) 
and indeterminate colitis (IC) is a chronic condition that is commonly diagnosed in childhood 
or adolescence. Around 15 to 25 percent of individuals with IBD are diagnosed before the 
age of 20 (1). The incidence of paediatric IBD is reported to be increasing in Europe and 
North America although reasons for this remain unknown (2). 
 
IBD is characterised by an unpredictable illness course and includes symptoms of abdominal 
pain, diarrhoea, nausea, fatigue, delayed puberty and weight loss. These symptoms, in 
addition to treatment (including surgery, steroid injections or having a colostomy bag) can be 
embarrassing, socially limiting and can lead to changes in physical appearance. This may 
have a negative impact on body image, self-esteem and mood (3-5). The social constraints of 
the disease, in addition to the considerable amount of school often missed due to illness and 
hospital appointments, may impact on social functioning (3,4). Significantly, the family 
dynamics may be altered resulting in the child having fewer opportunities to develop 
autonomy as they grow older.  
 
How does IBD effect psychosocial functioning/health related quality of life? 
The burden of living with IBD, as identified in adults (6), may be even greater in the 
developing child. If developmental tasks and transitions are halted, greater psychosocial 
difficulties and reduced health related quality of life (HRQOL) might be expected. 
Difficulties in these areas have been shown to have an adverse impact on treatment adherence 
(7) and may predispose children to developing more severe psychological or psychiatric 
conditions later in life. In addition to this, recent prospective studies examining the 
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pathogenic role of psychological stress in adults with IBD have revealed that individuals with 
heightened anxiety and depression are at a higher risk of further disease activity (8).  
 
Psychosocial functioning/HRQOL and its measurement 
HRQOL, including physical, psychological and social functioning, can be defined as one 
means of assessing the burden of chronic illness. Studies tend to refer to either HRQOL or 
psychosocial functioning and typically examine the impact of IBD on areas such as 
behavioural, emotional and social functioning and self-esteem. In order to increase the 
sensitivity of the search for this review both terms were included and are used 
interchangeably.  
 
Psychosocial functioning or HRQOL are typically measured using validated structured 
interviews (allowing for diagnosis of psychiatric disorders) and/or validated norm-referenced 
questionnaires. Most questionnaires generate standardised T scores derived from the 
normative sample with which the measure was developed, and distinguish children who 
required mental health input from those who did not. Thus T scores are ‗cut-offs‘ that allow 
judgments to be made about the clinical significance of a young person‘s difficulties.  
 
Generic measures of HRQOL (e.g. PedsQL) (9), which compare children with IBD to healthy 
peers and children with other conditions, have been used in the past. While these allow easy 
comparison across illness groups, they may not be specific enough to reflect impaired 
functioning in young people with IBD. Researchers in Canada and The Netherlands have 
collaboratively developed and validated the IMPACT, a paediatric IBD specific questionnaire 
measuring six domains: bowel symptoms, systemic symptoms, social/functional concerns, 
body image, emotional concerns and test and treatment concerns (10,11). In addition to these 
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broad HRQOL measures, questionnaires that focus on specific symptoms (e.g. depression) or 
areas of functioning (e.g. social functioning) are also popular. 
 
Mackner and Crandall (12) highlight the benefits of including a comparison group when 
assessing psychosocial functioning/HRQOL. A control group (of healthy age-matched peers 
or those with another chronic illness) can identify problems that are specific to young people 
with IBD. While normative reference data is often used in the place of matched control 
groups, these data cannot account for cohort effects, geographical location and socio-
economic factors that may be specific to the population being studied. 
 
Objectives 
This is a growing area of research where various aspects of psychosocial functioning have 
been examined using a range of different measures. While the most recent review (12) 
summarises the literature up to 2006, it was non-systematic. As several articles have been 
published in the intervening years, it was felt timely for a systematic review to be conducted 
to evaluate this somewhat confused research literature in greater depth. There is increasing 
recognition that this population may be experiencing difficulties that could be ameliorated 
and intervention trials are already under way to evaluate the efficacy of psychological 
treatments (13). A thorough examination of the evidence to date is therefore clinically 
relevant.  
 
This review seeks to identify the relevant literature focussing on psychosocial functioning 
and HRQOL in young people with IBD, to critique the methodological quality of this 
literature, discuss the implications of the findings and make recommendations for future 
 
 
12 
 
research and clinical practice. The following review question is proposed in order to address 
this:  
What impact does IBD have on psychosocial functioning and HRQOL in children and 
adolescents? 
 
Methods 
Search strategy: 
In order to identify suitable studies the following electronic databases: Ovid MEDLINE, 
EMBASE, PsychINFO, British Nursing Index, HMIC, EBSCO (CINHAL) and Web of 
Science were searched using the following search terms including the Boolean operator 
―AND‖: 
 
[affect or emotion or psychosocial or quality of life or depression or self esteem or self 
concept or stress or attitude or aggression or shy or social or coping or body image or 
anorexia or body dysmorphia or social interaction or well being or mental health or mood or 
mental disorder or behaviour or anxiety or anxious or anger or fear or frustration or peer or 
agoraphobia or eating disorder or bulimia or mood disorder or interpersonal relations or life 
style or lifestyle or autonomy or self efficacy or social perception or psychology or 
psychiatry]  
AND  
[adolescent or pediatric or paediatric or child or children or youth or young person or young 
people or teen] 
AND  
[crohn or colitis or inflammatory bowel disease].  
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Due to the wide-ranging definitions of HRQOL and psychosocial functioning these detailed 
search terms were chosen in order to increase the sensitivity of the search. A multi-database 
search was conducted using the text-words above in addition to searching each database 
individually using subject headings. The results of the subject heading search informed the 
final text-word search. The references of the most recent review (12) were examined to 
ensure no appropriate studies had been missed.  
 
Inclusion/exclusion criteria: 
All studies retrieved by the database search were examined using the following inclusion 
criteria. Those not meeting these criteria were excluded from the review. 
 Published in a peer reviewed journal between the years of 1990 and 2009 
 Study examined data from original research 
 Study is written in English 
 Study uses quantitative methods 
 Participants aged 18 years or younger 
 Participants have a medically confirmed diagnosis of CD, UC or IC 
 Outcome measures include HRQOL or aspects of psychosocial functioning (e.g. 
social/behavioural functioning, self-esteem, body image, depression or anxiety) 
 Established or standardised questionnaires are used 
 
Data extraction and quality rating: 
Studies meeting inclusion criteria were quality rated by the author using a checklist adapted 
from those outlined by SIGN (14) and CASP (15) (see Appendix 1.2). Studies were rated on 
17 items in four main areas: selection of participants, assessment, confounding factors and 
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statistical analysis. For each item it was possible to score 2 if the item was well covered, 1 if 
adequately covered, or 0 if poorly covered giving a total possible score of 34. A quality rating 
percentage score of good (>75%), acceptable (>50%) or poor (<50%) was awarded to each 
study.  
 
Fifty percent of studies were randomly selected and independently rated by another 
researcher using the same quality rating scale. There was 100% agreement between raters for 
the assignment of papers to quality rating categories. Following quality rating, 
methodological, demographic and clinical information was systematically extracted from 
each article. 
 
Results 
The database search identified 2141 articles. Of these, 1863 were either duplicates or were 
not deemed relevant to the current review and were excluded on the basis of title.  Abstracts 
of the remaining 278 articles were examined using full inclusion criteria, resulting in the 
exclusion of a further 252 articles. This left 26 potentially appropriate articles, 14 of which 
were excluded after reviewing the full text (10,11,16-27) (see Figure 1). The 12 remaining 
articles were deemed suitable to be included in the review and are discussed below (4,5,28-
37).  
 
INSERT FIGURE 1 HERE 
 
Demographic and methodological information 
The identified studies had a total of 5330 participants between the ages of 4 and 18 years 
(mean: 14.1 years). 790 participants had IBD and 4540 were controls (4474 healthy, 20 
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headache, 20 diabetes, 26 functional gastrointestinal complaints). 10 studies (n=706) 
provided information on disease type (66% CD, 31% UC and 3% IC) and 10 studies (n=740) 
reported gender (54% male and 46% female) (see Table 1).  
 
INSERT TABLE 1 HERE 
 
Eleven of the studies were cross-sectional observational studies and one used a prospective 
longitudinal design (36).  Four studies (33%) did not have a control group (5,28,36,37), five 
(42%) used either matched controls recruited at the time of the study (4,29,35), another 
illness group (32), or illness groups and healthy controls (31). Three studies (25%) used 
previously collected reference group data (30,33,34).  
 
Time since diagnosis varied widely between studies from zero months (5,36), more than one 
to two months (28), more than three months (35), more than six months (30,33,34) to more 
than one year (4). From the available information (four studies did not report time since 
diagnosis) the average duration of disease was 2.74 years. Only six studies reported disease 
severity in categories that could be compared between studies (4,5,33,34,36,37). In these 
studies (n=539) 36% had mild, 45% intermediate/moderate and 19% severe disease activity. 
 
A wide range of standardised assessments were administered via questionnaires and 
clinician-led interviews. The majority of studies included both self- and parent-report 
questionnaires (four used self-report measures only). Four studies conducted standardised 
diagnostic interviews with either the child (31) or the child and parent (5,28,37).  
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Quality rating revealed that three articles (5,28,30) scored in the ‗acceptable‘ range (>50%) 
while the remaining nine papers scored in the ‗good‘ range (>75%) (see Appendix 1.3). 
Methodological shortcomings will be discussed in relation to the results as they arise below. 
 
Psychosocial functioning  
The five main outcomes (self-esteem; HRQOL; anxiety and depression; social competence; 
and behavioural problems/functioning) identified will be considered separately in order that 
comparisons can be made between studies. It should be noted that a mean of four outcome 
assessments (range 1-11) were used in each study and therefore the same studies will be 
discussed in relation to different outcomes. For this reason Table 1 provides a summary of 
each study in its entirety for reference. In interpreting psychosocial functioning/HRQOL 
scores, larger or increasing scores indicate better functioning unless otherwise stated.   
 
Self-esteem  
Self-esteem was measured using standardised, validated self-report questionnaires in five 
studies (4,30-33). Only one of these studies, using a measure of self-esteem, ‗I think I am‘ 
(ITIA), developed in Sweden (38), found that young people with IBD had significantly 
lowered self-esteem compared to healthy controls (Fr=8.46, p>0.04) (31). T scores were not 
provided making it difficult to determine if the reduction in self-esteem was clinically 
significant. Additionally, this study used 20 outcome measures on a small sample (n=20) 
without adjusting significance levels for multiple comparisons. Another study using ITIA as 
the only outcome measure (33) found no significant difference in self-esteem between young 
people with IBD and a previously assessed healthy reference group.  
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Two studies using the Piers-Harris Children‘s Self-Concept Scale (PHCSCS) (39), a more 
commonly used measure yielding T scores, also found no significant difference in self-
esteem between young people with IBD and healthy controls (4,32). Indeed Gold et al. (32) 
found that young people with IBD actually had significantly better self-concept than the 
normative group. It should be noted that participants in both of these studies had mild disease 
activity.  In line with these findings De Boer et al. (30), using the Dutch version of the Self 
Perception Profile for Adolescents (SPPA; Harter) (40), did not find young people with IBD 
had lowered self-esteem. They did, however, find that self-esteem was a good predictor of all 
domains of HRQOL, but were unable to make any assumptions about the direction of 
causality.  
 
HRQOL 
Five articles assessed HRQOL (29,30,34-36). The two studies that administered generic 
multi-dimensional HRQOL instruments (29,30) had somewhat conflicting results. Using the 
Child Health Questionnaire (CHQ) (41,42) Cunningham et al. (29) found that while parents 
reported their children with IBD to be more impaired than healthy controls in the overall 
areas of physical health (F=50.17, p<0.001) and psychological health (F=5.789, p<0.05); 
young people themselves did not report more difficulties except in the general health 
subscale. In contrast, De Boer et al. (30) found that adolescent boys with IBD self-reported 
significantly worse overall HRQOL than the reference group (p<0.01). Some methodological 
limitations, however, should be borne in mind when interpreting these results. Although the 
HRQOL measure (Dutch Children‘s AZL/TNO Quality of Life Questionnaire, DUCATQOL) 
(43) administered was reported to be internally consistent and reproducible, no validation 
studies have yet been published. Furthermore, the age range of the reference data did not 
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match that of participants resulting in unsatisfactory analysis (females with IBD could not be 
compared to controls in two out of four domains of the DUCATQOL).   
 
Two studies using an IBD specific HRQOL measure, the IMPACT (10,11), in addition to 
generic HRQOL questionnaires, found that HRQOL was significantly lower in young people 
with IBD (34,35). Loonen et al. (34) analysed their data by two age strata in accordance with 
the normative data for the generic HRQOL measure (TNO-AZL Children‘s Quality of Life 
questionnaire, TACQOL) (44). They found that although adolescents (12-18 years, n=65) had 
significantly lower HRQOL than healthy peers on four domains (body complaints, motor 
functioning, autonomy and negative emotions) (p<0.05), younger children (8-11 years, n=18) 
had comparable or better HRQOL than controls. It should be noted that the small sample of 
younger children had mainly inactive or mild disease. Marcus et al. (35) found that young 
people reported significantly lower HRQOL than matched healthy controls on both the IBD 
specific IMPACT (p<0.001) and on a well established generic measure of HRQOL (PedsQL 
4.0) (9) (p<0.001). The remaining study to use the IMPACT was a large multi-site 
prospective cohort study that administered the questionnaire to 218 young people with IBD 
(36). Mean HRQOL scores significantly improved from baseline during the first year post 
diagnosis (p<0.05) (36).  
 
Mood (anxiety and depression) 
Seven studies investigated anxiety and depression using either structured diagnostic 
interviews or self-report questionnaires. It should be noted that increasing scores on anxiety 
and depression measures indicate increasing levels of distress. 
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Structured diagnostic interviews 
Four studies (5,28,31,37) used standardised clinical interviews with either children or their 
parents. These studies found that young people with IBD had increased levels of psychiatric 
disturbance or symptoms of depression and anxiety meeting DSM-III-R criteria (45). 
Prevalence varied from 25% (37) to 73% (5). Engstrom (31) compared 20 young people with 
IBD to headache, diabetes and healthy controls using the Child Assessment Schedule (CAS) 
(46) and found that significantly more young people with IBD fulfilled criteria for psychiatric 
disorder (mainly depression or anxiety) than the three control groups (2=11.34, p<0.01).  

The results of the other three studies using structured diagnostic interviews should perhaps be 
approached with caution. Burke et al. (28) and Szajnberg et al. (5) recruited newly or recently 
diagnosed young people with IBD and administered the Kiddie Schedule for Affective 
Disorders and Schizophrenia (K-SADS) (47). Although this is a well validated semi-
structured interview, both studies had small sample sizes of 36 (28) and 15 (5) and no control 
groups. Burke et al. (28) found that 42% of children with a mean disease duration of 3.5 
months reported symptoms of depression, while Szajnberg et al. (5) reported that 73% of 
their sample had psychiatric diagnoses at the time of their IBD diagnosis.  
 
Although Szigethy et al. (37) omitted a control group, they had a much larger sample of 102 
young people with IBD. They used the Schedule for Affective Disorders and Schizophrenia 
for School Aged Children – Present and Lifetime Version (SADS-PL) (48) interview with 19 
children scoring above the clinical cut-off (>12) on a self-report questionnaire (the Children‘s 
Depression Inventory, CDI) (49). They reported that this confirmed a clinically significant 
diagnosis of depression in 16 out of the 19 interviewed and uncovered previously 
undiagnosed co-morbid anxiety disorders in 11 of these individuals.  
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Self-report questionnaires 
Four studies administered the CDI, a self-report measure of depression, to young people 
giving mixed results (4,31,32,35). Whilst Engstrom (31) found young people with IBD 
reported significantly more depressive symptoms than healthy controls (Fr=10.00, p<0.02), 
the other three studies did not find evidence of increased symptoms of depression in 
comparison with healthy controls (4,35) or another illness group (32). Two of these studies 
(4,31) also assessed anxiety using a self-report measure; the Revised Children‘s Manifest 
Anxiety Scale (RCMAS) (50); they both failed to find increased symptoms of anxiety in the 
IBD group compared to controls. 
 
Social competence 
Three studies examined social competence as an outcome (4,31,32). Engstrom (31) and Gold 
et al. (32) used a parent-report questionnaire, the Child Behaviour Checklist (CBCL) (51), 
while Mackner and Crandall (4) administered the self-report version, the Youth Self Report 
form (YSR) (52). Both measures have a social competence scale in which an increasing score 
indicates better social functioning. While two studies (4,32) found social competence to be in 
the normal range and comparable to controls, Engstrom (31) found that mothers rated their 
children with IBD as significantly less socially competent than healthy children (Fr=7.86, 
p<0.04). Given the small sample size and large number of other measurements used in this 
study, however, it would be prudent to interpret these results with caution (e.g. by adopting a 
more conservative significance level).  
 
Behavioural problems/functioning 
Four studies examined behavioural functioning using either the CBCL (30-32) or YSR (4). 
These measures yield a total behavioural problems score as well as internalising behaviour 
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(withdrawn, somatic complaints and anxious/depressed) and externalising behaviour (rule-
breaking and aggressive behaviour) scores. For these domains, an increasing score indicates 
greater levels of behavioural problems.  
 
Engstrom (31) found that young people with IBD had significantly more total behavioural (2 
Fr=9.34, p<0.03) and internalising behaviour (
2 
Fr=9.83, p<0.02) problems than healthy 
controls. De Boer et al. (30), comparing young people with IBD to a healthy reference group, 
found significant differences on the total behavioural problems (p<0.05) and internalising 
behaviour subscales (p<0.01) for boys, while for girls the only significant difference was 
found for internalising behaviour (p<0.05). In contrast, Gold et al. (32) and Mackner and 
Crandall (4) found mean scores in the normal range and no significant differences between 
young people with IBD and controls. It was noted, however, that a subset of 20% of 
participants with IBD reported clinically impaired levels of behavioural/emotional 
functioning (4).  
 
Discussion 
The reviewed studies present a somewhat mixed picture of psychosocial functioning/HRQOL 
in children and adolescents with IBD. While the evidence for decreased HRQOL and 
increased incidence of psychiatric disorders seems fairly consistent across studies, the 
evidence for lowered self-esteem, symptoms of depression and anxiety (measured by self-
report measures), impaired social competence and behavioural functioning is less clear due to 
conflicting results. In order to make sense of these findings, confounding factors that may 
have influenced outcomes will be considered and placed in the context of other research.  
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Self-report vs. parent report 
The majority of studies assessing self-esteem using self-report measures found that young 
people with IBD reported comparable self-esteem to healthy peers. These findings are 
surprising given the number and extent of bodily changes associated with IBD e.g. steroidal 
weight gain, surgical scars and colostomy bags. In comparison with adults, children and 
adolescents with IBD often have the added burden of delayed puberty and slowed growth. In 
a study using a disease specific HRQOL instrument, the IMPACT, body image was found to 
be impaired in adolescents with IBD (34). Research on the incidence of body image 
disturbances in children with IBD, although studied in other chronically ill children (e.g. 
those with diabetes), is conspicuously absent from the research literature.  
 
In making sense of the unimpaired levels of self-esteem, in addition to the inconsistent 
evidence for anxiety and depression, the discrepancy between findings of studies using self-
report and parent-report measures needs to be considered. Research findings indicate that 
young people with IBD may have difficulty reporting psychological symptoms (31) and tend 
to report fewer symptoms compared with their parents (22,23,29). A study by Canning (53) 
found a similar discrepancy in reporting with a sample of children with other chronic 
illnesses (including cancer, cystic fibrosis and diabetes) and their parents. In the healthy 
comparison group, however, children reported symptoms more frequently than their parents 
(53).  
 
It has been suggested that the under-reporting or minimising of symptoms seen in young 
people with IBD could be due to denial which may be adaptive in buffering them from 
experiencing the full impact of the disease. Indeed two studies have found that young people 
with IBD tend to use more avoidant coping styles than healthy peers (27,31).  Conversely, it 
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is possible that young people with IBD are reporting symptoms accurately and it is their 
parents, who are themselves depressed, anxious or over-involved with their children, that are 
pathologising normal behaviour and over-reporting symptoms compared to parents of non-
chronically ill children.  
 
Disease severity 
Disease severity may also contribute to the variation in results. Increased disease severity was 
found to correlate with increased depression (37), lowered self-esteem (33) and decreased 
HRQOL (29,35,36). It seems intuitive that young people experiencing more severe symptoms 
would report lower HRQOL than those in remission. Most of the studies reviewed had large 
proportions of participants categorised with either ‗mild‘ or ‗moderate‘ disease severity. 
Therefore information about the difficulties experienced by individuals with more severe 
symptoms may be missing. The underrepresentation of this group may also make correlations 
between severity and psychosocial functioning more difficult to see. A number of studies 
found no association between disease severity and psychopathology (4,17,18,28).  
 
There is, however, some evidence that psychosocial factors are more predictive of emotional 
and behavioural functioning than disease factors (24,28). Indeed, low socio-economic status 
has been found to correlate with increased depression (32) and decreased self-esteem (33), 
while parental separation correlated with reduced self-esteem (33). This is consistent with 
research in the general population where these factors are considered to increase risk for 
psychological difficulties (54). It is of interest to note that children with IBD have a 
consistently higher proportion of co-habiting or married parents than those in healthy control 
groups (31). Perhaps parents stay together to care for their sick child, or alternatively young 
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people from more stable family backgrounds are more likely to have their IBD diagnosed and 
treated.  
 
Age  
Age may also be predictive of HRQOL. Loonen et al. (34) found that while adolescents with 
IBD had impaired HRQOL, younger children had comparable or better HRQOL than healthy 
peers. A longitudinal study examining HRQOL over the first year of diagnosis (36) reported 
that for each increasing year of age, there was an associated five point decrease in self-
reported HRQOL. Similarly, Szigethy et al. (37) noted that diagnosis later in childhood was 
associated with increased depressive symptoms. It is possible that IBD has a greater 
detrimental impact on the adolescent‘s ability to complete developmental tasks (such as 
developing independence and autonomy) and subsequently causes greater psychological 
distress. In light of these findings, examining children and adolescents as one group may lead 
to difficulties being masked. Additionally, the validity of making comparisons between 
developmentally delayed adolescents with IBD and controls matched on chronological age 
should be questioned.  
 
Time since diagnosis 
Individuals with a wide range of disease durations were included in the reviewed studies, 
from recent onset to more than one year post diagnosis. While Burke et al. (28) did not find 
HRQOL scores were predicted by time since diagnosis, they were examining recent-onset 
cases (<1-2 months). A longitudinal study found improvements in HRQOL over the first six 
months following diagnosis which persisted over the course of the first year (36). Difficulties 
in psychosocial functioning/HRQOL seen prior to six months post-diagnosis are perhaps 
more likely to be normal adjustment reactions to being acutely unwell and receiving a 
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diagnosis of a chronic illness. Therefore the stage at which HRQOL is assessed may 
determine what is actually being measured and affect the results. 
 
Strengths and weaknesses of the evidence  
The reviewed studies have a number of methodological limitations which make interpreting 
this body of evidence quite challenging. The frequent lack of comparison groups and reliance 
on normative data makes it difficult to determine whether differences are due to cohort 
effects or impact of the disease. While there may not be large numbers of young people with 
IBD experiencing clinically significant symptoms, there may be subsets that are impaired and 
would benefit from extra support from their Gastroenterology team. Standardised, validated 
measures that provide T scores would allow the clinical significance of results to be 
determined.  
 
The small sample sizes, which are common and often unavoidable in paediatric research, 
make it more difficult to determine the validity of significant results. None of the included 
studies based sample size on a power calculation and only one calculated effect sizes for their 
results. The majority of studies included participants from a wide age-range with varying 
disease severity and disease durations. This review indicates that these factors may have an 
influence on HRQOL and as such should be considered carefully in the study design and 
analysis. Inclusion and exclusion criteria were often not reported in sufficient detail. All 
studies, bar one, used a cross-sectional design which means causality cannot be determined.  
 
It should be noted, however, that more recently published studies appear to be addressing 
some of the limitations outlined above. Otley et al.‘s (36) ongoing longitudinal study will 
provide valuable information about HRQOL over time. Since the validation of an IBD 
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specific HRQOL measure (the IMPACT) a growing number of studies are reporting robust 
results that allow easy comparison. There has also been an increase in the use of objective, 
standardised disease severity rating questionnaires (such as the Pediatric Crohn‘s Disease 
Activity Index; PCDAI) (55) allowing for more accurate recording and better comparison 
between studies. 
 
Strengths and weaknesses of the review 
This review used an extensive search strategy to identify all relevant studies to the review 
question. The strict inclusion and exclusion criteria ensured that only articles with a high 
level of methodological quality were included. Despite these strengths there are several 
weaknesses that should be considered when interpreting the conclusions of this review. Due 
to time constraints it was not possible to conduct hand searches of major journals in the field 
nor to independently quality rate all included studies. For the same reason, unpublished 
studies and articles not available in English were not included in the review. This may have 
resulted in a publication bias in the included studies. Due to the diverse measures used on a 
wide range of outcomes it was not possible to conduct statistical analysis in this review.  
 
Conclusions  
Due to the conflicting findings, methodological variation and limitations of the research in 
this field only tentative conclusions can be drawn. Young people with IBD appear to be at a 
higher risk of reduced HRQOL and of developing psychiatric conditions such as anxiety or 
depression compared to their healthy peers. There may be a higher incidence of low self-
esteem, self-reported symptoms of depression and anxiety, impaired social competence and 
internalising behaviour problems.  
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More research, however, is required. This needs to take into account the discrepancy in child 
and parent reporting by using multiple informants; addressing the issue of disease severity by 
either ensuring groups are more homogenous or using statistical techniques to adjust for 
variation; and addressing the issue of age by examining children and adolescents separately. 
In order to avoid pathologising normal adjustment reactions and labelling young people with 
psychiatric diagnoses, only those who have had sufficient time to adjust to their IBD 
diagnosis should be recruited. Ensuring studies have larger sample sizes informed by a power 
calculation where appropriate, using standardised well-validated measures, and reporting 
results more consistently would increase the quality of this area of research. Research into 
body image would be timely as this appears to be an under-researched area.  
 
Developing a clearer understanding of the impact of IBD on HRQOL and psychosocial 
functioning would be beneficial for clinical staff working with this illness group as it would 
allow early interventions to be targeted to those most at risk. This may prevent more serious 
mental health problems, difficulties with adherence, and possibly increased disease activity in 
the future. 
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Databases searched using search terms: 
 Ovid Medline 
 EMBASE 
 PsychInfo 
 British Nursing Index 
 HMIC 
 EBSCO – CINHAL 
 WOK – Web of Science 
between the dates 1990 – Dec 2009  
 
Articles identified  n = 2141 
 
Titles and abstracts screened 
 
n = 278 
Excluded     n = 1863 
Duplicates removed and articles 
excluded on the basis of title  
 
 
Full copies of potentially appropriate 
articles retrieved and reviewed using full 
inclusion/exclusion criteria 
 
n = 26 
Excluded    n = 252 
 Not child or adolescent sample 
 Not original journal article 
 Not published in peer reviewed 
journal 
 Not available in English 
 Medical rather than 
psychological focus 
 Focus on parent rather than 
child 
 
Publications included in Systematic 
Review 
 
n = 12 
Excluded    n = 14 
 Secondary data from another 
included study n = 5 
 Primary outcome not HRQOL 
or psychosocial function n = 1 
 No clear outcome data n = 3 
 Not standardised measures n= 2 
 Other n = 3 
 
 
Figure 1: Flow chart of study selection process 
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Study Country  Participants 
(IBD: n) 
(Controls: n) 
Age 
range  
Diagnosis 
(CD, UC 
or IC) 
Time since 
diagnosis 
Outcomes 
assessed 
Assessments  Self-report 
or parent-
report  
Significant results 
Burke et al., 
1994 
USA IBD: 36 
No control 
group 
No info 
 
Mean 
age: 
11.98yrs 
CD or UC >1-
2months  
 
Mean 
duration: 
3.5months 
Depression 
Anxiety  
 
(maternal 
depression 
life events 
family 
relationships) 
Kiddie-SADS 
interview  
FRI  
A-SADS-L 
interview  
FILE  
 
Parent & 
self-report 
14% met diagnostic 
criteria for  major 
depression, 28% for 
atypical depression 
10 children had a 
history of anxiety.  
The depressed group 
was less severely ill 
than the non 
depressed group 
(p=0.006) 
 
Cunningham 
et al., 2007 
USA IBD: 49 
Healthy 
controls: 49 
10-18 yrs 
 
Mean 
age: 
14.96yrs 
 
‗IBD‘ no 
further 
info  
No info 
 
Mean 
duration: 
no info 
 
 
HRQOL Child Health 
Questionnaire 
(CHQ)  
Parent & 
child 
versions 
 
 
 
 
Parent report: IBD 
group significantly 
impaired HRQOL 
compared to controls 
(Physical Health 
score p<0.000, 
Psychosocial score 
p<0.05).  
Child report: No 
significant 
differences in 
HRQOL compared 
to controls (except in 
general health). 
 
Table 1: Table summarising studies included in systematic review 
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De Boer et 
al., 2005 
Netherlands IBD: 40 
Healthy 
children: 1359 
(reference data 
DUCATQOL) 
12-18 yrs 
 
Mean 
age: 
15.2yrs 
CD, UC 
or IC 
>6 months 
 
Mean 
duration: 
3.8yrs 
HRQOL 
Self-esteem 
Anxiety (trait) 
Behaviour 
problems 
DUCATQOL  
Dutch version 
SPPA 
Dutch version 
STAI 
CBCL  
Self-report 
x3, parent 
completed 
CBCL 
Boys with IBD had 
significantly worse 
HRQOL (p<0.01) & 
more behavioural 
problems (p<0.05) & 
internalising 
behaviour (p<0.01) 
compared to healthy 
peers. Girls had more 
internalising 
behaviour (p<0.05) 
only. No significant 
differences in state 
anxiety or self-
esteem compared to 
controls.  
 
Engstrom, 
1992 
Sweden IBD: 20 
Headache 
control: 20 
Diabetes 
control: 20 
Healthy control: 
20  
7-18 yrs 
 
Mean 
age: 
16.5yrs 
UC or CD  No info 
 
Mean 
duration 
4.2yrs 
(range 1.0-
8.2yrs) 
Psychological  
adjustment 
Social 
competence 
Well-being 
Emotional 
adjustment 
Psychiatric 
disorders 
Self-esteem 
Depression 
Anxiety 
Cognitive abilities 
CBCL  
Frisk Well-
being scale  
Rotter 
sentence 
completion 
test 
ITIA 
CDI  
RCMAS  
Raven‘s 
matrices 
CAS  
Parent-
report, self-
report & 
child  
interview 
On most variables 
children with IBD 
had highest levels of 
psychiatric 
disturbance i.e. IBD 
> healthy children 
for behaviour 
problems (p<0.03); 
social competence 
(p<0.04); emotional 
adjustment 
(p=0.001); 
psychiatric disorders 
(p=0.01); self-esteem 
(p<0.01) & 
depression (p<0.02). 
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Gold et al., 
2000 
Canada IBD: 36 
Functional 
Gastrointestinal 
Complaints 
(FGI) controls: 
26 
 
8-18 yrs 
 
Mean 
age: 
13.31yrs 
UC or CD 
 
Excluded 
if had a 
colectomy 
No info  
 
Mean 
duration: 
2yrs 
Depression 
Self-concept 
Social adjustment 
CBCL  
CDI  
Piers Harris 
Children‘s Self 
concept 
Questionnaire 
developed by 
researchers  
Self-report 
& parent-
report  
IBD group were less 
depressed & had 
fewer behaviour 
problems than 
controls (p=0.03). 
No scores were in 
the clinical range. 
Children with IBD 
have a higher than 
average self-concept. 
 
Lindfred et 
al., 2008 
Sweden IBD: 71 
Previously 
collected healthy 
reference group: 
1037  
Normative data 
from ITIA: 2662 
 
10-16 yrs 
 
Mean 
age: 
14.6yrs 
CD, UC 
or IC 
>6 months  
 
Mean 
duration: 
2.9yrs 
Self-esteem I think I am 
(ITIA)  
 
Self-report No significant 
difference in self-
esteem between IBD 
group & comparison 
or normative group. 
Loonen et 
al., 2002 
Netherlands IBD: 83 
Dutch school 
children 
controls: 1810 
8-18 yrs 
 
Mean 
age: 
14.3yrs 
 
CD, UC 
or IC 
>6 months  
 
Mean 
duration: 
no info 
HRQOL TACQOL 
IMPACT III 
(NL) 
Self-report Adolescents with 
IBD had 
significantly lowered 
HRQOL on 4 
domains (p<0.05). 
Younger children 
had comparable or 
better HRQOL than 
healthy peers.  
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Mackner & 
Crandall, 
2005 
USA IBD: 50 
Healthy 
controls: 42 
11-17yrs 
 
Mean 
age: 
14.69yrs 
CD, UC 
or IC 
>1 year 
 
Mean 
duration: 
3.53yrs 
Psychosocial 
functioning: 
Behavioural/ 
emotional 
functioning 
Social 
competence 
Self-esteem 
Coping strategies 
Social support 
 
YSR  
CDI 
RCMAS 
PHSCS 
Coping 
Strategies 
Inventory 
Social Support 
Questionnaire 
 
Self-report No significant 
differences on any 
measures.  
Marcus et al., 
2009 
USA IBD: 70 
Healthy 
controls: 157 
10-17yrs 
 
Mean 
age: 
14.1yrs 
CD, UC 
or IC 
>3months 
 
Mean 
duration: 
34 months 
HRQOL 
Fatigue 
PEDS-QL 
Multi-
dimensional 
Fatigue Scale  
PEDS-QL 4.0 
IMPACT III  
CDI-SF  
 
Self-report 
& parent-
report 
IBD group had 
significantly lower 
generic HRQOL than 
healthy controls 
(p<0.0001). No 
significant difference 
in depressive 
symptoms between 
IBD & controls.  
 
Otley et al., 
2006 
USA & 
Canada 
IBD: 218 
No controls 
>9yrs 
 
Mean 
age: 
12.7yrs 
CD, UC 
or IC 
0 months – 
followed up 
to 1 year  
 
 
HRQOL IMPACT III Self-report Significant 
improvement in 
HRQOL scores 1yr 
post-diagnosis 
(p<0.05).  
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Szajnberg et 
al., 1993 
USA IBD: 15 
No controls 
No info 
(appears 
to be 
4.92-
15yrs)  
 
Mean 
age: 
11.6yrs 
CD or UC 0 months Psychopathology 
child & parent 
Maternal 
attachment 
Attachment 
related disorders 
in children 
(separation 
anxiety, 
dysthymia/ 
depression) 
OCD disorder 
children 
K-SADS-P 
interview  
AAI 
CBCL  
MCMI  
Locke Wallace 
Mental Scale 
FILE 
IOF 
COBI 
Irvine 
Sentence 
Completion 
Test  
WISC-R 
TAT 
 
Mostly 
parent-
report or 
interview 
with 
parents. 
Some 
interview 
/assessment 
of child but 
no self-
report 
measures 
73% had DSM-III 
diagnoses 
(predominantly 
separation anxiety & 
major depression), a 
significant number 
showed internalising 
behaviour (p<0.01). 
Szigethy et 
al., 2004 
USA IBD: 102 
No controls  
11-17yrs 
 
Mean 
age: 14.7 
yrs 
CD or UC No info 
 
Mean 
duration: 
2.4yrs 
(range 0-
9.7yrs) 
Depression 
(& its relationship 
with disease 
factors)  
CDI  
SADS-PL if 
scored >12 on 
CDI 
 
Self-report, 
clinical 
interview 
with child 
& parent 
High rates of 
clinically significant 
depressive symptoms 
in older children & 
adolescents with 
IBD. 25% had 
depressive symptoms 
(>12 CDI) & 16/19 
psychiatrically 
interviewed had 
clinically significant 
depressive disorder. 
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Key to terms used in Table 1 
 
 
AAI: Adult Attachment Interview 
A-SADS-L: Adult Schedule for Affective 
Disorders 
and Schizophrenia, Lifetime Version 
CAS: Children‘s Assessment Schedule 
CBCL: Child Behaviour Checklist 
CDI: Child Depression Inventory (SF: short form) 
DUCATQOL: The Dutch Children‘s AZL/TNO 
Quality of FILE: Family Inventory for Life Events 
FRI Family Relationship Index Scale 
ITIA: I think I am 
IOF: Impact of Events Scale 
 
IMPACT III: IBD specific HRQOL instrument 
K-SADS-P: Kiddie Schedule for Affective 
Disorders and Schizophrenia 
MCMI: Millon Clinical Multi-Axial Inventory 
PHSCS: Pier‘s Harris Children‘s Self-Concept 
Scale 
RCMAS: Revised Children‘s Manifest Anxiety 
Scale 
SADS-PL: Schedule for Affective Disorders  
and Schizophrenia for School Aged Children  
– Present & Lifetime Version 
SPPA: Self Perception Profile for Adolescents 
(Dutch version) 
STAI: State-Trait Anxiety Inventory for Children 
(Dutch version) 
TACQOL: TNO-AZL Children‘s Quality of Life  
TAT: Thematic Apperception Test 
WISC-R: Weschler Intelligence Scale Revised 
YSR: Youth Self-Report Scale 
Life Questionnaire 
COBI: Clinician‘s Objective Burden Index 
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Abstract  
Background: The onset of Inflammatory Bowel Disease (IBD) is highest during adolescence. 
The symptoms may make the essential developmental transitions associated with this stage 
more challenging and cause difficulties in psychosocial functioning. While previous research 
has compared adolescents with IBD to healthy controls, it may be more informative to take a 
developmental approach, examining psychosocial functioning within the early, mid and late 
stages of adolescence.  
Aims: The primary aim of this exploratory study was to investigate whether stage of 
adolescence has an effect on social functioning, body image and self-esteem in adolescents 
with IBD. The secondary aims were to determine whether stage of adolescence has an effect 
on mood, and whether demographic and disease factors have an effect on outcome measures. 
Methods: 63 adolescents aged between 11 and 17 years with IBD were recruited from a 
gastroenterology outpatient clinic. Each adolescent completed measures of social functioning, 
body image, self-esteem and mood. Demographic and disease information was also gathered. 
Outcome measures were compared between the three groups (early, mid and late 
adolescence) using parametric and non-parametric statistical tests. 
Results: There were no significant differences in any of the outcomes between the three 
groups. The only significant finding from regression analysis was that gender significantly 
predicted self-esteem. Nearly half the sample reported impaired social functioning and a 
quarter had significant levels of anxiety. 
Conclusions: Stage of adolescence was not found to have an effect on psychosocial 
functioning or mood in this population. The small sample size, assigning developmental 
groups according to age and the mild disease severity of participants limit the conclusions 
that can be drawn from this study.  
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Introduction 
Inflammatory Bowel Disease (IBD) is caused by chronic inflammation of the gastrointestinal 
tract and comprises three disorders: Crohn‘s disease (CD), ulcerative colitis (UC) and 
indeterminate colitis (IC). These conditions can cause recurring symptoms including frequent 
diarrhoea, abdominal pain, fatigue, perianal disease, poor appetite, nausea, delayed puberty, 
weight loss and growth delay. The onset of IBD within childhood years is reported to be 
highest in adolescence (1). 
 
Adolescence and IBD 
During adolescence, there are a number of biological, psychological and social changes that 
may make coping with a chronic disease more challenging (2). From a psychosocial 
perspective the tasks of adolescence are to establish an identity, develop peer and romantic 
relationships and establish greater independence and autonomy (3). Adolescence can be 
considered as consisting of three developmental stages: early (ages 11-13), middle (14-15) 
and late (16-18), although some degree of overlap is inevitable (4).  
 
Early adolescence can be characterised by the tremendous assimilation of new experiences, 
including the physical changes of puberty and social changes such as moving to high school. 
These introduce new demands requiring more sophisticated social and cognitive skills. 
Conflict between young people and their parents tends to increase at the start of puberty, 
while greater importance is placed on friendships and being part of the crowd.  
 
In mid adolescence there is a peak in preoccupation with others‘, especially peers‘, view of 
self (5). Self-esteem has been shown to dip in early to mid adolescence (6). At this stage 
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young people are often concerned with establishing their independence and autonomy, 
tending to spend more time with their friends, or alone, than with their parents.   
 
In late adolescence rising levels of self-esteem (7) are accompanied by decreasing levels of 
family conflict. Some young people may have developed formal operational cognitive skills 
(8) and be able to solve abstract problems. One of the key tasks of this stage is forming 
emotionally intimate partnerships, and beginning to develop a clear self-identity. At this stage 
adolescents may be more future oriented, thinking in terms of further education, jobs and life 
goals.   
 
The symptoms of IBD can make it more difficult for adolescents to complete the essential 
developmental transitions outlined above. During a ‗flare-up‘ when the disease is active, they 
may need to spend a great deal of time in the bathroom and fear becoming a target for 
‗bathroom humour‘. The perceived need to be near a bathroom at all times may also limit 
social activities. Adolescents are likely to miss considerable time off school due to illness and 
hospital appointments, affecting both academic work and peer relationships. 
 
Studies of psychosocial functioning 
Studies examining social functioning in adolescents with IBD have had mixed outcomes. 
Studies using self-report norm-referenced measures of social competence found mean scores 
in the average range (9,10), whilst others using comparison groups and parent-report 
measures found lower social competence scores in young people with IBD than in healthy 
comparison groups (11,12).  
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Some adolescents with IBD will undergo surgery or have a colostomy bag which can lead to 
reluctance to engage in peer or intimate relationships, as well as having an impact on body 
image. Delayed puberty and slowed growth, in addition to side effects from steroids such as 
weight gain or facial changes, may also impact on body image and self-esteem. There has 
been little research to date on the impact of IBD on body image, although population based 
studies suggest that adolescents with a chronic illness report higher body dissatisfaction than 
healthy adolescents (13). Loonen et al. (14) found adolescents with IBD had significantly 
impaired scores on the body complaints domain of a health-related quality of life (HRQOL) 
measure. Conversely, a more recent study using a norm-based scale to assess feelings about 
physical appearance found mean scores in the average range and no difference between 
young people with IBD and healthy controls (10). It should be noted, however, that to the 
author‘s knowledge no specific measures of body image have been administered to 
adolescents with IBD.  
 
Studies examining self-esteem in this population using norm-based questionnaires report 
mean scores in the average range (9,10,15) and comparable levels of self-esteem to healthy 
adolescent controls (16). Other studies using comparison groups, however, found that 
children and adolescents with IBD had significantly lower self-esteem than healthy controls 
(11,10).  
 
While relatively little research has examined the areas mentioned above, studies investigating 
the prevalence of mood disorders in this population are more numerous. A recent review 
concluded that young people with IBD were more likely to meet criteria for anxiety or 
depression than healthy peers, but that rates of mood disorder were similar to those associated 
with other chronic illnesses (17). Research examining depression in the general population 
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suggests adolescents who have completed puberty have significantly higher rates of 
depression than their pre-pubertal peers (18).  
 
HRQOL and IBD 
Recently, several studies have used HRQOL, encompassing physical, social and 
psychological functioning, as a primary outcome measure. There are a number of factors that 
may impact upon HRQOL/psychosocial functioning. Most studies have found girls to have 
lower HRQOL than boys (14), although others have found no gender differences (16,19). In 
the adult literature, females have been found to have lower HRQOL than males (e.g. 20).  
 
While HRQOL is found to improve significantly in the first six months post-diagnosis and 
then continue to improve throughout the first year (19), information on longer term 
functioning is not available. Disease type may impact on psychosocial functioning. The adult 
literature suggests patients with CD have reduced HRQOL compared to those with UC (e.g. 
21). Loonen et al. (14) reported that young people with CD had lower HRQOL scores than 
those with UC, although these differences were not significant. CD was found to have a 
greater impact on social functioning than UC in one study (22) although other researchers 
found no difference (16,10). 
 
Increasing age has been shown to be associated with more impaired psychosocial functioning 
and lower HRQOL (19,16,14). A longitudinal study of young people with IBD found that for 
each year of age gained, HRQOL scores decreased by five points (19). Recent cross-sectional 
studies report significant associations between age and self-esteem (with self-esteem being 
lower in mid adolescence) (16), and increasing age and more impaired emotional functioning 
(23). It has been suggested that this could be the result of the adolescent‘s increasing ability 
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to predict the long-term implications of their illness, in addition to the effects of IBD on their 
attainment of key developmental tasks (14).  
 
Rationale to the proposed research 
While research has started to examine the psychosocial sequelae of IBD in adolescents, it has 
primarily focussed on making comparisons between adolescents with IBD and their healthy 
peers. Adolescence is a time of transition, with a huge degree of heterogeneity within the 11 
to 18 age group, making regarding this population as homogenous questionable. It therefore 
seems useful to take a between stage approach to exploring the psychosocial consequences of 
IBD in adolescence. 
 
Lowered self-esteem, body dissatisfaction and impaired social functioning can be risk factors 
for later depression and anxiety (24); therefore, gaining a detailed picture of this population 
would have important service implications, allowing input to be targeted to the most 
vulnerable group to minimise the likelihood of future problems developing.  
 
The aim of this study was to investigate the impact of IBD on psychosocial functioning in 
early, mid and late adolescence by addressing the following research questions:   
(1) Does stage of adolescence have an effect on social functioning, body image and self-
esteem? 
(2) Does stage of adolescence have an effect on mood (anxiety and depression) and does 
mood correlate with social functioning, body image and self-esteem?  
(3) If numbers permit, do disease type (CD, UC or IC), disease severity, disease duration, 
gender and socio-economic status have an effect on social functioning, body image 
and self-esteem in adolescents with IBD?  
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From the available research, the following tentative hypotheses were proposed: 
(1) Younger adolescents will report less impairment in the areas of social functioning, 
body image and self-esteem than older adolescents.  
(2) Younger adolescents will report fewer symptoms of anxiety and depression than older 
adolescents.  
(3) Adolescents with CD will report greater impairment in the areas of social functioning, 
body image and self-esteem than adolescents with UC or IC. 
 
Methods 
This exploratory study uses a cross-sectional between groups design to compare psychosocial 
functioning in early, mid and late adolescence.  
 
Ethical considerations 
Ethical approval was granted by the West of Scotland Research Ethics Committee 
(09/S1001/54) as well as the local NHS Research and Development department 
(GN09GA437) (see Appendices 2.2-2.5).  
 
Participants 
Adolescents attending the gastroenterology outpatient clinic at The Royal Children‘s Hospital 
in Glasgow were recruited. All young people with a diagnosis of IBD in the west of Scotland 
attend this clinic and 170 of these are adolescents. Adolescents diagnosed for more than six 
months with CD, UC or IC, aged between 11-18 years old and attending mainstream high 
school were eligible for the study. Participants who had serious comorbid medical conditions, 
major psychiatric diagnoses or who had a level of impaired cognitive functioning which 
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would prevent them from being able to give informed consent or complete the questionnaires 
were excluded.  
 
Justification of sample size  
While no studies examining psychosocial functioning between the stages of adolescence 
could be identified, studies comparing psychosocial functioning and HRQOL in adolescents 
with IBD to healthy controls reported medium effect sizes (12,14,15). These papers provided 
the best available indication of likely effect size.  
 
An initial power calculation
1
, taking significance criterion (alpha) to be 0.05 and effect size to 
be medium (f = 0.25 according to Cohen, 26) indicated that a sample of 159 was required to 
give power of 0.8. Information from the research site, however, indicated a maximum of 100-
110 adolescents as a realistic target in the available time period. With a sample of 105 (35 per 
group), a medium effect size (f = 0.25) and a significance criterion of 0.05, this study would 
have power of 0.6 to detect significant differences between groups.  
 
Procedures 
Two concurrent recruitment procedures were used to maximise sample size. Adolescents 
fulfilling inclusion criteria were either sent information packs the week prior to their 
outpatient appointment, or were sent information packs, consent forms and questionnaires at 
any time during the data collection period (December 2009 to April 2010) (see Appendix 2.6 
and 2.7). The former (clinic) group were approached at the outpatient clinic and invited to 
participate. The latter (postal) group were asked to sign consent forms and return them by 
post. Reminders were sent to non-responders after three weeks. In order to encourage 
                                                          
1
 Calculated using an online power calculator (27). 
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participation gift vouchers were awarded to participants and all information packs included a 
covering letter co-signed by the Consultant Paediatrician (see Appendix 2.8). Of 132 
adolescents approached 63 agreed to take part (48% response rate).  28 (44%) were recruited 
at clinic and 35 (56%) via postal methods.  
 
Several measures (outlined below in the order they were administered) were used to gather 
information on psychosocial functioning. Participants recruited at the clinic were asked to 
complete questionnaires in a clinic room after giving consent. This took under 20 minutes 
during which time the main researcher was present in order to provide assistance where 
required. Participants recruited through the postal method signed appropriate consent forms 
and returned these in a pre-paid envelope. They then completed questionnaires assisted by an 
‗instruction sheet‘ (see Appendix 2.9) and returned these in a separate envelope. 
  
Measures 
1. Social competence scale of The Youth Self Report checklist (YSR) (27) 
This is one of the most widely used standardised assessments for measuring social 
competence in adolescents. The self-report social competence scale measures 
participation in hobbies, games, sports, chores, friendships and activities. Higher 
scores indicate better social competence. The YSR has adequate psychometric 
properties (27) and yields T scores which are a useful indicator of clinical 
significance.  
 
2. Revised Body-Esteem Scale (RBES) (28) 
This measures adolescents‘ attitudes and feelings about their body and appearance. 
There are three subscales: general feelings about appearance, weight satisfaction, and 
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evaluations attributed to others about one‘s body and appearance. Respondents 
indicate their degree of agreement with 23 statements (e.g. ―I like what I look like in 
pictures‖) using a five-point scale (see Appendix 2.10). This has been shown to be 
valid and reliable in a wide age range (29). Higher scores indicate better levels of 
body-esteem.  
 
3. The Rosenberg Self-Esteem Scale (RSES) (30,31) 
This is a widely used and well validated brief (10 item) measure of global self-esteem 
for use with adolescents. Participants indicate the extent to which they agree with 
statements (e.g. ―On the whole, I am satisfied with myself‖) on a four point scale. 
Higher scores indicate better self-esteem. 
 
4. Hospital Anxiety and Depression Scale (HADS) (32)  
This is a brief (14 item) self-report measure developed for use with adult medical out-
patients. Construct and concurrent validity have now been demonstrated in physically 
ill adolescents (aged 12-17) (33). The questionnaire has two subscales; one for 
depression and one for anxiety. A possible limitation was the use of the HADS with 
11 year olds; however, by including only 11 year olds that had entered high school, 
participants should have had adequate cognitive skills to complete this measure. For 
this age group, it has been suggested that scores >9 and >7 indicate clinically 
significant symptoms of anxiety and depression respectively (33).  
 Demographic information including age, gender, socio-economic status (by post-code 
using the Scottish Index of Multiple Deprivation, SIMD) (34) and family composition 
was collected via a brief (four item) questionnaire given to adolescents (see Appendix 
2.11).  
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 Current disease severity was measured using the Pediatric Crohn‘s Disease Activity 
Index (PCDAI) (35) and the Pediatric Ulcerative Colitis Activity Index (PUCAI) (36). 
The PCDAI and PUCAI have good reliability and validity and are collected routinely 
by the gastroenterology team.  
 
 Additionally, information on total number of admissions to hospital, length of time in 
hospital, disease duration, current medication, referral to psychology and whether the 
adolescent had undergone resectional or non-resectional surgery was gathered from 
patient files.  
 
Data Analysis  
Data screening revealed that data was normally distributed for some outcomes (social 
functioning and self-esteem) and non-normally distributed for others (body image, depression 
and anxiety). As a result either parametric or their non-parametric equivalents were used 
where appropriate. A Kruskal-Wallis one-way analysis of variance was conducted to compare 
demographic variables between the three groups. 
 
Primary analyses: Psychosocial functioning was compared between the three age groups 
(early, mid and late) using analysis of variance (ANOVA) for social functioning and self-
esteem, and Kruskal-Wallis for body image, depression and anxiety.  
 
Secondary analyses: A Spearman‘s rho was conducted to determine whether mood (anxiety 
and depression) correlated with social functioning, body image and self-esteem. A pre-
planned multiple linear regression analysis was conducted to determine the effect of other 
variables on outcome. Social functioning was used as the outcome variable while age, gender, 
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socio-economic status (SES), disease type (CD or UC), disease duration, disease severity 
(coded as ‗active‘ or ‗in-remission‘ from PCDAI or PUCAI scores) and stage of adolescence 
were entered as predictors in a single entry procedure. This was repeated for self-esteem (the 
only other variable to meet the assumptions for regression).  The poorest predictors were 
excluded so that the final model included gender, diagnosis, SES and stage of adolescence. 
On the basis of the results of the regression, interactions between gender and stage of 
adolescence were added to the model. The difference between the two models was compared 
using an F-test. All analyses were performed using SPSS version 18. 
 
Results 
Demographic features of sample 
Data was gathered from 63 adolescents between 11 and 17 years of age (mean: 13.75 years, 
SD 1.7). There were 27 adolescents in the early, 25 in the mid, and 11 in the late group. There 
was a nearly equal ratio of males to females (32:31), 68% had CD, 21% UC and 11% IC. 
Participants had a mean disease duration of 3.3 years (SD 2.1) and the majority were either in 
remission (57%) or had mild disease activity (38%). 33% of the total sample had been 
referred for psychological input. No significant differences were found between groups on 
demographic variables apart from admissions to hospital (p<0.05) (see Table 1).  
 
INSERT TABLE 1 HERE 
 
Clinical significance 
Clinical normative data were only available for the YSR and HADS. Mean YSR social 
competence T scores were in the ‗normal range‘ for 55%, ‗borderline range‘ for 10% and 
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‗clinical range‘ for 35% of the whole sample (n=582). The HADS provides clinical cut-offs 
for anxiety and depression. In this sample (n=63) 11% and 27% reported clinically significant 
symptoms of depression and anxiety respectively (see Table 2 and Appendix 2.12).   
 
INSERT TABLE 2 HERE 
 
Stage of adolescence and psychosocial functioning (including mood) 
There were no significant differences between the early, mid and late groups on any outcome 
measures: social functioning (F(2) = 1.12, ns), self-esteem (F(2) = 0.07, ns), body image 
(H(2) = 1.93, ns), anxiety (H(2) = 1.18, ns)  or depression (H(2) = 0.26, ns) (see Table 3). All  
effect sizes were small (see Table 4). Both depression and anxiety were found to be positively 
correlated with each other and significantly negatively correlated with body image and self-
esteem (p<0.01) but only depression was significantly negatively correlated with social 
functioning (p<0.01). All outcomes significantly correlated with one another with the 
exception of body image and social functioning (see Table 5). 
 
INSERT TABLES 3, 4 AND 5 HERE 
 
Other factors that may influence psychosocial functioning 
Multiple linear regression using gender, diagnosis
3
, SES and stage of adolescence as 
predictor variables with social functioning and self-esteem as outcomes, revealed that only 
gender significantly predicted the outcome of self-esteem (p<0.01). Females were more likely  
                                                          
2
 Some participants did not fully complete the YSR. Missing data was dealt with by excluding cases listwise. 
3 
Only CD and UC were used in the regression due to the small number of participants in the IC group. 
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to have low self-esteem than males. The addition of the interaction between gender and stage 
of adolescence to the regression model did not significantly predict social functioning or self-
esteem (see Tables 6 and 7).  
 
INSERT TABLES 6 AND 7 HERE 
 
Discussion 
Synopsis of findings 
The results of this study suggest that levels of psychosocial functioning do not differ between 
early, mid and late adolescence in young people with IBD. There were no significant 
differences in any of the outcomes between the three age groups. Overall social competence 
was not found to be more impaired in the IBD sample than for the healthy population from 
which normative data were gathered, and mean depression and anxiety scores were below 
clinical cut-offs. There were quite sizeable subsets, however, of adolescents with clinically 
significant levels of impaired social functioning and anxiety. Nearly half the sample reported 
impaired social functioning and a quarter had significant levels of anxiety. Regression 
analysis found that gender significantly predicted self-esteem, with females showing more 
impairment than males. There was no effect of disease type, disease severity, duration of 
disease or SES on the outcomes of social functioning or self-esteem. Correlations between 
measures of mood and psychosocial functioning were all significant and in the expected 
direction apart from those between social functioning and anxiety, and social functioning and 
body image; both of these were non-significant but in the expected direction. 
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Possible explanations in the context of existing research 
Stages of adolescence and psychosocial functioning  
The main finding, that psychosocial functioning does not appear to be influenced by 
developmental stages, corresponds with studies where correlations between age and HRQOL 
in adolescents with IBD were not found (15,37). Other studies, however, provide evidence 
that age is correlated with HRQOL (14,19), self-esteem (16) and emotional functioning (23). 
It is possible that age does play a role but the small sample size of this study provided 
insufficient power to detect significant differences between groups. The small effect sizes, 
however, would suggest that even with a much larger sample significant differences between 
groups (particularly for self-esteem and body image) would not have been seen. Therefore, 
either developmental stage has no effect on psychosocial functioning and the primary 
hypothesis can be rejected, or there is an alternative explanation as to why differences were 
not seen between groups in this study.  
 
Some variation with age would be expected across adolescence particularly for self-esteem 
(6) and depression (18). The similarity of scores between groups in the present study is 
therefore noteworthy. Perhaps the small size of the ‗late adolescence‘ group and the failure to 
recruit any 18 year olds resulted in numbers that were insufficient to show these trends.   
 
An alternative explanation may be that defining the age ranges of the three groups in 
accordance with established theories of adolescent development (4) is inappropriate for this 
population. Many adolescents with IBD complete puberty at a later age than those in the 
general population. Therefore it is possible that the adolescents making up the groups defined 
by chronological age were not as homogenous as had been hoped, potentially affecting group 
comparisons. Nevertheless, even when age was considered as a continuous variable it failed 
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to correlate with psychosocial outcomes suggesting this finding was not purely due to 
incorrect grouping. 
 
Psychosocial functioning in IBD vs. healthy adolescents 
The present study found mean scores for social functioning and mood comparable to those 
expected for healthy adolescents. This corresponds with a number of studies examining social 
functioning (9,10), anxiety (38,10) and depression (9,10,39). There are, however, a number of 
studies providing conflicting evidence: that social functioning is impaired (38) and levels of 
anxiety and depression are higher (38,40-42) in adolescents with IBD. It is noteworthy that 
the majority of these studies used either structured diagnostic interviews or parent-report 
measures, while most of the studies which did not find differences, including the present 
study, used self-report questionnaires. It has been suggested that young people with IBD tend 
to report fewer psychological symptoms compared to their parents‘ reports of them 
(14,17,43). This may be due to the use of more avoidant coping styles, such as denial (37,38). 
Alternatively, it is possible young people with IBD report symptoms accurately and it is their 
parents who tend to over-report difficulties.  
 
There has been very little research into the effect of IBD on body image and, to the author‘s 
knowledge, this is the first study to examine it as a main outcome. Adolescents did not have 
lowered mean scores for the three subscales of the RBES in any of the three age groups. It 
was hypothesised that side effects of steroid medication and the physical changes associated 
with surgery would affect body image; however, in this sample only 18% were taking acute 
medication at the time of participation, and only 14% had undergone surgery.  
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Other confounding factors 
The unimpaired levels of overall psychosocial functioning found in this study could also be 
explained by the majority of participants either being in remission or having mild disease 
severity. This participant bias was unavoidable for two reasons: firstly adolescents feeling 
physically better are more likely to participate, and secondly, following instruction by the 
Ethics Committee and clinical guidance from the gastroenterology team, adolescents who 
were acutely unwell during the recruitment phase were not approached. While some studies 
have reported an association between increased disease severity and lowered psychosocial 
functioning/HRQOL (16,19,39,41,43), others have failed to find evidence of this 
(10,23,40,44). In the present study, no correlation was found between disease severity and 
psychosocial functioning or mood. Given the small number of participants with severe 
disease, however, this is perhaps unsurprising.   
 
The finding that 33% of participants had been referred for psychological input was 
interesting. This figure may be an underestimation as it only includes adolescents referred to 
the psychology team within the hospital. Adolescents who had received psychological input 
could be expected to have improved psychosocial functioning. The Royal Children‘s Hospital 
has a gastroenterology multi-disciplinary team with the dedicated input of two Clinical 
Psychologists. It is possible that this psychologically informed way of working has reduced 
overall psychosocial distress in adolescents attending the clinic. 
 
This study found adolescent girls were significantly more impaired than boys in the area of 
self-esteem but not social functioning
4
. This corresponds with a number of studies reporting 
                                                          
4
 It was not possible to make comparisons for body image, anxiety and depression due to data violating 
parametric assumptions. See analyses/results section.  
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gender differences in psychosocial functioning/HRQOL in young people with IBD (37,45), 
although others have failed to uncover gender differences (16,19). It makes sense that 
adolescents with IBD would mirror the general population where girls are more at risk of 
lowered self-esteem than boys (46).  
 
In line with some previous research the present study did not find an association between 
psychosocial functioning and disease type (9), disease severity (17,23) or SES (16). While 
other studies have found disease type (44), disease severity (41,46) and SES (9) to impact 
upon psychosocial functioning, it is possible this sample was too small for differences to be 
detected.  
 
Limitations of the present study and methods used to minimise or compensate for these 
There are some limitations that should be considered when interpreting the results of this 
study. The greatest limitation is the small sample size which is responsible for the low power 
to detect significant differences. This is, however, common and often unavoidable in 
paediatric research. The low response rate was disappointing and may have resulted in 
participant bias (with more physically and psychologically well adolescents taking part). An 
unequal age distribution resulted in a smaller ‗late adolescence‘ group. This is, however, 
representative of the clinic population where many adolescents start to transfer to local adult 
services from the age of 16. The predominance of participants that were in remission or with 
mild disease activity has been discussed. 
 
Organisational constraints such as time and cost influenced the selection of measures. In 
order to ensure questionnaire completion time remained under 20 minutes, as recommended 
by the Ethics Committee, brief measures were selected. Two of the measures originally 
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proposed for anxiety and depression were deemed too costly and were replaced by a 
questionnaire that was available free of charge. Some of the measures used in this study 
(RBES and RSES) did not yield age-related T scores or provide clinical cut-offs, making it 
difficult to determine the clinical significance of the results. Due to time constraints it was not 
possible to recruit healthy controls. It would have been beneficial to compare the non-
significant patterns seen in the IBD sample with a healthy aged-matched comparison group to 
determine whether these were specific to IBD or a normal feature of adolescent development. 
 
In some respects the HADS was a highly appropriate measure of mood as it was developed 
specifically for patients with physical health difficulties. It is, however, primarily an adult 
measure despite being validated for adolescents (33) and may have been unsuitable for 
younger participants. A paediatric version of the HADS has recently been published (47) and 
would be more appropriate for future research.  
 
The PCDAI and PUCAI, which allow collection of standardised disease severity scores, 
should be completed within one week of seeing the patient. This was not possible for some 
participants recruited via the postal method who had not attended the clinic for several 
months. Their scores were estimated by the Paediatric Gastroenterologist from their most 
recent appointment and blood results. An additional unforeseen problem was the lack of 
information on pubertal status in patient files. It had been hoped to gather this information to 
examine within group homogeneity and determine the developmental validity of the three 
groups but this was not possible.  
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Clinical and research implications of this study 
This study is the first to examine psychosocial functioning from a developmental perspective 
and investigate body image in adolescents with IBD. The clinic from which young people 
were recruited provides specialist care to the entire west of Scotland. Therefore the sample 
consisted of individuals from a wide range of urban and rural locations of varying socio-
economic levels.  
 
By using specific measures of psychosocial functioning this study aimed to gather more 
detailed information than would be possible from a broad HRQOL measure. Although the 
study did not identify one age group that was more at risk of psychosocial difficulties, it did 
reveal that a sizeable subset of adolescents with IBD have impaired social functioning and 
increased levels of anxiety.  
 
Clearly more research is required to further understand this complex area. Longitudinal 
studies would provide valuable information on adjustment to diagnosis and psychosocial 
functioning over time. Due to the low effect sizes, studies with large samples would be 
required. Including greater numbers of older adolescents would allow more accurate 
comparisons between developmental stages. Given the frequent disparity between pubertal 
timing and growth in adolescents with IBD compared to their healthy age-matched peers, it 
would be advantageous to use information on pubertal status and physical development in 
addition to chronological age to define developmental groups. Recruiting adolescents with 
more severe disease activity, who have undergone surgery and are on aggressive treatment 
regimes might result in greater effect sizes. Gathering information from several different 
informants (e.g. self-, parent- and proxy-reports) and using a healthy comparison group 
would also be beneficial. Selecting measures that are sensitive to young people‘s distress 
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would make it possible to determine whether adolescents with IBD are resilient or whether 
they are indeed experiencing difficulties in psychosocial functioning as a result of their 
disease. This enhanced understanding would facilitate identification (perhaps through routine 
screening) of those most at risk of experiencing difficulties so that early psychological 
intervention could be offered in order to prevent future, more serious problems with mood 
and adherence.  
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Table 1: Demographic and disease information for the overall sample and the three age groups. 
Characteristic 
Overall 
Sample 
(n=63) 
Early 
(11-13yrs) 
(n= 27) 
Mid 
(14-15yrs) 
(n= 25) 
Late 
(16-18yrs) 
(n= 11) 
Sig. 
Age in years: mean (SD) 13.75 (1.7) 12.07 (0.8) 14.44 (0.5) 16.18 (0.4)  
Gender: n (%) 
Male  
Female  
 
32 (51) 
 31 (49) 
 
13 (48) 
14 (52) 
 
13 (52) 
12 (48) 
 
6 (55) 
5 (45) 
0.93 
SES: mean deciles (SD) 5.00 (2.7) 4.70 (2.5) 5.04 (3.0) 5.64 (2.6) 0.66 
Family composition: n (%) 
Mother & father 
Mother 
Mother& stepfather 
 
48 (76) 
12 (19) 
3 (5) 
 
20 (74) 
 6 (22) 
1 (4) 
 
19 (76) 
5 (20) 
1 (4) 
 
9 (82) 
1 (9) 
1 (9) 
0.93 
Number of siblings: n (%)                     
0 
1 
2 
3 
4 
8 (12.7) 
29 (46) 
17 (27) 
7 (11.1) 
2 (3.2) 
 
2 (7) 
15 (56) 
8 (30) 
2 (7) 
0 
 
5 (20) 
12 (48) 
3 (12) 
3 (12) 
2 (8) 
1 (9) 
2 (18) 
6 (55) 
2 (18) 
0.21 
Type of disease:  n (%) 
CD 
UC 
IC 
 
43 (68) 
13 (21) 
7 (11) 
 
18 (67) 
5 (19) 
4 (15)  
 
16 (64) 
7 (28) 
2 (8) 
 
9 (82) 
1 (9) 
1 (9) 
0.62 
Disease duration in months: 
Mean (SD) 
39.75 (24.8) 35.22 (25.8) 41.44 (25.8) 47.00 (18.4) 0.18 
Disease severity 
(PCDAI/PUCAI)   n (%) 
Remission 
Mild  
Moderate 
 
 
36 (59)
 1
 
24 (39) 
1 (2) 
 
 
18 (69)
 2
 
8 (31)  
0 
 
 
13 (54)
 3
 
10 (42) 
1 (4) 
 
 
5  (45) 
6 (55) 
0 
0.48 
Number of admissions to 
hospital: mean (SD) 
2.52 (1.5) 2.22 (1.2) 2.28 (1.4) 3.82 (2.0) 0.03* 
Length of time in hospital 
(days): mean (SD) 
9.08 (10.0) 7.30 (9.1) 8.92 (9.8) 13.82 (11.8) 0.14 
Surgery n (%) 
No surgery 
Non-resectional  
Resectional  
 
54 (86) 
2 (3) 
7 (11) 
 
25 (93) 
0 
2 (7) 
 
20 (80) 
2 (8) 
3 (12) 
 
9 (82) 
0 
2 (18) 
0.43 
Acute medication (steroids 
or enteral feeds) n (%) 
No  
Yes  
 
 
52 (83) 
11(17) 
 
 
23 (85) 
4 (15) 
 
 
19 (76) 
6 (24) 
 
 
10 (91) 
1 (9) 
 
 
0.50 
Referral psychology n (%) 
No  
Yes 
 
42 (67) 
21  (33) 
 
18 (67) 
9 (33)  
 
18 (72) 
7 (28) 
 
6 (55) 
5 (45) 
0.60 
*Significant p<0.05 using a Kruskal-Wallis test  
 1 n=61: 2 missing as no colons,      2 n=26: 1 missing as no colon,       3 n=24: 1 missing as no colon 
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Table 2: Clinical cut-offs for social functioning, anxiety and depression for the whole sample 
and three age groups. 
 
Measure 
Whole 
Sample 
(n=63) 
Early  
(n=27) 
Mid 
 (n=25) 
Late  
(n=11) 
Range YSR activities: n (%) 
Normal 
Borderline 
Clinical 
 
40 (63.5) 
12 (19.0) 
11 (17.5) 
 
21 (77.8) 
2 (7.4) 
4 (14.8) 
 
13 (52) 
8 (32) 
4 (16) 
 
6 (54.5) 
2 (18.2) 
3 (27.3) 
Range YSR Social: n (%) 
Normal 
Borderline 
Clinical 
 
51 (83.6) 
7 (11.5) 
3 (4.9)
a
 
 
24 (92.3) 
1 (3.9) 
1 (3.9)
b
 
 
19 (79.2) 
3 (12.5) 
2 (8.3)
c
 
 
8 (72.7) 
3 (27.3) 
0 
Range T score: n (%) 
Normal  
Borderline 
Clinical 
 
32 (55.2) 
6 (10.3) 
20 (34.5)
d
 
 
16 (64) 
4 (16) 
5 (20)
e
 
 
11 (45.8) 
2 (8.3) 
11 (45.8)
f
 
 
5 (55.6) 
0 
4 (44.4)
g
 
Depression > clinical cut-off: n 
(%) 
7 (11.1) 2 (7.4) 2 (8) 3 (27.3) 
Anxiety >clinical cut-off: n (%)  17 (27) 6 (22.2) 6 (24) 5 (45.5) 
 
Some participants did not fully complete the YSR Social scale. Therefore some data is missing: 
a
n=61 (2 missing),  
b
n=26 (1 missing), 
c
n=24 (1 missing),      
d
n=58 (5 missing),   
e
n= 25 (2 missing),  
f
n=24 (1 missing),  
g
n=9 (2 missing)                          
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Table 3: Psychosocial functioning compared between early, mid and late adolescence. 
 
 
Age group 
 p value 
EARLY MID LATE 
Social Functioning * 
Total competence score 
YSR 
Mean (SD) 
 
 
 
20.1 (4.1) 
 
 
18.3 (4.5) 
 
 
19.00 (4.7) 
 
 
0.33 
Self-esteem * 
Total score RSES 
Mean (SD) 
 
21.4 (4.9) 20.3 (6.2) 21.8 (6.7) 0.93 
Body Image   
Total score RBES 
Median (interquartile-
range) 
 
62 (42-71) 60 (46.5-69.0) 59 (22-74) 0.99 
Depression   
HADS–D total score 
Median (interquartile-
range) 
 
1 (0-5) 2 (0.5-4.5) 4 (1-8) 0.38 
Anxiety  
HADS–A total score 
Median (interquartile-
range) 
 
6 (2-8) 7 (4-8.5) 8 (3-13) 0.55 
* Where data are normally distributed means and standard deviations are reported and ANOVA were 
used 
    Where data are not normally distributed medians and interquartile ranges are reported and 
Kruskall-Wallis tests were used 
 
 
 
Table 4: Effect sizes (r) for psychosocial functioning outcomes. 
 
Measure 
Early and Mid 
Adolescence 
Mid and Late 
Adolescence 
Early and Late 
Adolescence 
Social Functioning 0.21 0.07 0.12 
Self-Esteem 0.06 0.02 0.03 
Body Image 0.02 0.00 0.02 
Anxiety 0.11 0.05 0.15 
Depression 0.05 0.19 0.21 
 
Note: Effect sizes according to Cohen: 0.10 = small effect, 0.30 = medium effect, 0.50 = large effect.  
All effect sizes are small.  
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Table 5: Correlations between mood (anxiety and depression) and psychosocial functioning 
(social functioning, self-esteem, body image) 
 
Variable 
     Social 
Functioning 
Body Image Self-Esteem Depression Anxiety 
Social Functioning (rs) -     
Sig.      
Body Image (rs) .199 -    
Sig. .134     
Self-Esteem (rs) .426* .696* -   
Sig. .001 .000    
Depression (rs) -.395* -.687* -.833* -  
Sig. .002 .000 .000   
Anxiety (rs) -.253 -.567* -.780* .749* - 
Sig. .055 .000 .000 .000  
* Correlation is significant at the 0.01 level (2 tailed). 
 
 
Table 6: Multiple regression with interaction between gender and stage of adolescence for social 
functioning. 
 
Model  SE   t Sig. 
Step 1      
(Constant) 21.19 1.51  13.08 0.00 
Gender -2.10 1.18 -0.25 -1.78 0.08 
Early-mid adolescence -1.76 1.28 -0.21 -1.37 0.18 
Early-late adolescence -2.36 1.77 -0.20 -1.34 0.19 
SES 0.00 0.00 0.11 0.77 0.45 
Disease type (UC/CD) -1.54 1.40 -0.15 -1.10 0.28 
Step 2      
(Constant) 20.87 1.76  11.86 0.00 
Gender -1.86 1.86 -0.22 -1.00 0.32 
Early-mid adolescence -2.01 1.90 -0.24 -1.06 0.30 
Early-late adolescence -0.89 2.56 -0.08 -0.35 0.73 
SES 0.00 0.00 0.13 0.90 0.37 
Disease type (UC/CD) -1.37 1.42 -0.14 -0.96 0.34 
Gender × Early-Mid  0.51 2.59 0.05 0.20 0.84 
Gender × Early-Late -2.97 3.56 -0.19 -0.83 0.41 
Note: R
2
= 0.14 for Step 1; R
2
 =0 .16 for Step 2. 
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Table 7: Multiple regression with interaction between gender and stage of adolescence for self-
esteem. 
 
Model  SE   t Sig. 
Step 1      
(Constant) 22.38 1.90  11.81 0.00 
Gender -4.39 1.53 -0.37 -2.87 0.01* 
Early-mid adolescence -1.28 1.70 -0.11 -0.75 0.46 
Early-late adolescence -0.95 2.20 -0.06 -0.43 0.67 
SES 0.00 0.00 0.19 1.48 0.15 
Disease type (UC/CD) -1.85 1.84 -0.13 -1.01 0.32 
Step 2      
(Constant) 21.04 2.16  9.76 0.00 
Gender -2.90 2.37 -0.24 -1.23 0.23 
Early-mid adolescence -1.02 2.44 -0.08 -0.42 0.68 
Early-late adolescence 2.82 3.10 0.18 0.91 0.37 
SES 0.00 0.00 0.24 1.81 0.08 
Disease type (UC/CD) -1.48 1.83 -0.11 -0.81 0.42 
Gender × Early-Mid  -0.45 3.34 -0.03 -0.14 0.89 
Gender × Early-Late -7.50 4.33 -0.36 -1.73 0.09 
Note: R
2
= 0.19 for Step 1; R
2
 =0 .24 for Step 2.      *p>0.01 
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Abstract 
 
In this account I chose to reflect on an experience in my specialist placement of struggling to 
write verbatim process notes after seeing a client with whom I was working using a 
psychodynamic approach. This experience prompted me to reflect on my personal and 
professional development, and therefore felt beneficial to consider in more depth. Johns‘ 
model of reflection (1994) was chosen to structure the account as it seemed to best fit with 
the psychodynamic approach I was trying to get to grips with.  
 
As guided by Johns‘ model (1994), the experience is described followed by a reflection of 
what happened and how I felt at the time. Then both internal and external influencing factors 
are considered before alternative strategies are discussed. Finally I discuss my feelings about 
the reflection, what I have learnt and how I make sense of the experience in light of past 
experience and future practice.  
 
In reviewing the reflection I note the change in my emotions throughout the process of 
writing the account, as well as the similarities between this and the feelings experienced in 
the incident I have described (writing the process notes). The impact of gaining experience of 
the psychodynamic approach is discussed in relation to my current and future practice. While 
my opinion of the current climate regarding access to, and Trainee Clinical Psychologists‘ 
experience of, psychodynamic interventions is also discussed.  
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Abstract 
This account details my reflections around the process of setting up advanced experiences in 
a placement agreement for my final Advanced Professional Practice placement.  My feelings 
at discovering I may not be able to gain essential experience of consultation, supervision and 
contributing to team functioning are discussed. The requirements to become competent in the 
wide ranging role of the Clinical Psychologist within a multi-disciplinary team are discussed 
in the context of the doctoral training programme‘s Intended Learning Outcomes, recent 
government policy and the British Psychological Society‘s National Occupational Standards.  
 
Johns‘ model of reflection (1994) was chosen to guide the reflection. After describing the 
experience and reflecting on my feelings and actions at the time, I consider both internal and 
external influencing factors that may have contributed to these. Any alternative strategies and 
their possible consequences are considered before I finally reflect on what has been learnt 
through the process. The action taken in trying to challenge the team‘s perception of my 
abilities and impress the importance of gaining experience on placement is also discussed.  
 
This was followed by a meta-reflection on the process of writing the account as well as 
considering it in the context of current policy and the implications of this policy for both 
Trainee Clinical Psychologists and qualified Clinical Psychologists. The challenge of walking 
the ‗fine line‘, contributing to team management and offering consultation and supervision 
where appropriate while respecting team culture and expectations, is discussed.  
 
 
 
 
 
 
80 
 
APPENDICES 
 
Systematic review 
 
Major Research Project 
 
Appendix 1.1 Instructions for authors for the Pediatric Journal of 
Gastroenterology and Nutrition 
 
81 
Appendix 1.2 Quality rating and data extraction form  
 
84 
Appendix 1.3 Quality rating of studies included in systematic review 
 
86 
Appendix 2.1  Instructions for authors for Inflammatory Bowel Diseases 
 
87 
Appendix 2.2  Letter of ethical approval 
 
90 
Appendix 2.3  Letter of ethical approval for amendment 
 
93 
Appendix 2.4  Letter of R&D approval 
 
95 
Appendix 2.5  Email of R&D approval for amendment 
 
96 
Appendix 2.6  Information sheet – clinic version 
 
97 
Appendix 2.7  Consent form – young person 
 
100 
Appendix 2.8  Covering Letter  
 
101 
Appendix 2.9  Instruction sheet for filling in questionnaires – postal 
version 
 
102 
Appendix 2.10  Revised Body Esteem Scale 
 
104 
Appendix 2.11  Demographic Questionnaire 106 
 
Appendix 2.12 Table a 
 
Table b  
      
Table c 
Multiple regression for predictors and outcomes for self-
esteem 
Multiple regression for predictors and outcomes for social 
functioning 
Mean scores and scores for subscales on measures of  
 psychosocial functioning 
 
107 
Appendix 2.13  Major Research Proposal: The impact of inflammatory 
bowel disease on psychosocial functioning in early, mid and 
late adolescence.  
 
108 
 
 
81 
 
APPENDIX 1.1 
Journal of Pediatric Gastroenterology and Nutrition 
Online Submission and Review System 
 
SCOPE 
The Journal of Pediatric Gastroenterology and Nutrition publishes original articles, special 
reports, review articles, rapid communications, case reports, letters to the editor, and news 
and views on all aspects of pediatric gastroenterology, hepatology, and nutrition. 
 
The journal follows the International Committee of Medical Journal Editors' Uniform 
Requirements for Manuscripts Submitted to Biomedical Journals (URM). Manuscripts must 
be prepared in accordance with the URM (N Engl J Med 1997; 336:309-15 and updated at 
http://www.icmje.org/). Manuscripts not prepared according to the Instructions to 
Authors will be returned to the author(s) without review.  
 
 
MANUSCRIPT PREPARATION 
Manuscripts that do not adhere to the following instructions will be returned to the 
corresponding author for technical revision before undergoing peer review. Concise, clearly 
written articles are more likely to be accepted for publication in the Journal of Pediatric 
Gastroenterology, JPGN. Authors whose first language is not English are encouraged to ask a 
native English-speaking colleague or a professional author's editor to edit their manuscript 
before submission. 
 
Title page: Include on the title page (a) complete manuscript title; (b) authors‘ full names, 
highest academic degrees, and affiliations; (c) name and address for correspondence, 
including fax number, telephone number, and e-mail address; (d) address for reprints if 
different from that of corresponding author; (e) all sources of support, including 
pharmaceutical and industry support, that require acknowledgment; and (f) disclosure of 
funding received for this work from any of the following organizations: National Institutes of 
Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s).  
 
Structured abstract and key words: Limit the abstract to 250 words. Do not cite references 
in the abstract. Limit the use of abbreviations and acronyms. Use the following subheads: 
Objectives, Methods, Results, and Conclusions. List three to five key words.  
Text: Organize the manuscript into four main headings: Introduction, Materials and Methods, 
Results, and Discussion. Define abbreviations at first mention in text and in each table and 
figure. If a brand name is cited, supply the manufacturer's name and address (city and 
state/country). 
 
Data Analysis: Description of data analyses should provide the specific methods used, their 
rationale, their assumptions, whether data met those assumptions, and how any missing data 
were handled.  
 
Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors 
Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, 
MD 20814) or other standard sources. Write out the full term for each abbreviation at its first 
use unless it is a standard unit of measure.  
References: The authors are responsible for the accuracy of the references. Key the 
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references (double-spaced) at the end of the manuscript. Cite the references in text in the 
order of appearance. Cite unpublished data—such as papers submitted but not yet accepted 
for publication and personal communications, including e-mail communications—in 
parentheses in the text. If there are more than three authors, name only the first three authors 
and then use et al. Refer to the List of Journals Indexed in Index Medicus for abbreviations of 
journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/lji.html. Sample 
references are given below: 
 
Journal article 
I. Guarino A, Spagnuolo MI, Giacomet V, et al. Effects of nutritional rehabilitation on 
intestinal function and on CD4 cell number in children with HIV. J Pediatr Gastroenterol 
Nutr 2002;34:366-71. 
 
Book chapter 
2. Todd VR. Visual information analysis: frame of reference for visual perception. In: 
Kramer P, Hinojosa J, eds. Frames of Reference for Pediatric Occupational Therapy. 
Philadelphia: Lippincott Williams & Wilkins; 1999:205-56. 
 
Entire Book 
3. Ming S-C, Goldman H. Pathology of the Gastrointestinal Tract. Philadelphia: Lippincott 
Williams & Wilkins; 1998. 
 
Software 
4. Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control and 
Prevention; 1994. 
 
Online journals 
5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial 
online] January 1988;71: 22-37. Available from: BRS Information Technologies, McLean, 
VA. Accessed December 15, 1990. 
 
Database 
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. 
Updated March 29, 1996. 
 
World Wide Web 
7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS web site]. June 1, 1996. Available 
at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997. 
 
Tables: Cite tables consecutively in the text, and number them in that order. Each table 
should be submitted as a separate document. Each table must have a title. Use footnotes to 
define abbreviations and for other explanatory detail in a legend below the Tables. Tables 
should be self-explanatory and must supplement, rather than duplicate, the material in the 
text. 
 
Figure legends: Each figure must have a legend. Legends should be brief and should be 
typed on a separate manuscript page after the references. Use scale markers in the image for 
electron micrographs, and indicate the type of stain used. 
 
Figures: Art should be created/scanned and saved and submitted as individual files in either 
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TIFF (tagged image file format), EPS (encapsulated PostScript), or PPT (PowerPoint) format. 
Line art must have a resolution of at least 1200 dots per inch (dpi), while electronic 
photographs (radiographs, CT scans, etc.) and scanned images must have a resolution of at 
least 300 dpi. If fonts are used in the artwork, they must be converted to paths or outlines or 
they must be embedded in the files. Color images must be created/scanned and saved and 
submitted as CMYK files. Please note that artwork generated from office suite programs such 
as CorelDRAW and MS Word and artwork downloaded from the Internet (JPEG or GIF files) 
cannot be used. Cite figures consecutively on the site, and number them in the order in which 
they are discussed. All electronic art that cannot be successfully uploaded must be submitted 
on a 3½-inch high-density disk, a CD-ROM, or an Iomega Zip disk, accompanied by high-
resolution laser prints of each image. 
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Study identification (author, title, year of publication, journal title, pages): 
 
 
 
 
 
Checklist completed by: 
 
SECTION 1: INTERNAL VALIDITY 
 
 Quality rating 
1.1  
The study addresses an appropriate and clearly 
focussed question. 
2  Well covered                     
1  Adequately covered    
0  Poorly addressed              
SELECTION OF PARTICIPANTS 
1.2 
Participants are recruited in a scientifically 
appropriate manner and are representative of the 
defined population. 
2  Well covered 
1  Adequately covered 
0  Poorly addressed 
1.3 
The cases and controls are taken from comparable 
populations (in all respects other than factor under 
investigation). 
2  Well covered                     
1  Adequately covered          
0  Poorly addressed               
1.4 
Inclusion and exclusion criteria are stated and the 
same exclusion criteria are used for both cases and 
controls. 
2  Well covered                     
1  Adequately covered          
0  Poorly addressed               
1.5 
The study indicates how many of the people asked to 
take part did so, in each of the groups being studied. 
2  Well covered                     
1  Adequately covered          
0  Poorly addressed               
1.6 
Comparisons are made between participants and 
non-participants to establish their similarities or 
differences. 
2  Well covered                     
1  Adequately covered          
0  Poorly addressed           
1.7 A control group is used 
2  Healthy children or another illness  pop.                 
1  Norms from a standardised measure          
0  No control group               
1.8 
Sufficient numbers of cases are selected and this was 
based on a power calculation. 
2  Well covered                     
1  Adequately covered          
0  Poorly addressed               
1.9 
Actual sample size is stated 
 
2  Well covered                     
1  Adequately covered          
0  Poorly addressed               
APPENDIX 1.2 Quality rating and data extraction form 
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ASSESSMENT 
1.10 The outcomes are clearly defined. 
2  Well covered                     
1  Adequately covered          
0  Poorly addressed               
1.11 
The study incorporates blinding where feasible (e.g. 
outcome is assessed blind if possible) 
2  Well covered                     
1  Adequately covered          
0  Poorly addressed      
          
1.12 
Methods are used to enhance the quality of 
measurements (e.g. self-report or  multiple 
informants vs. proxy report) 
2 Self-report or self-report & proxy-report                     
1  Proxy-report (parent or clinician)          
0  Mixed methods or not specified       
         
1.13 
Assessment measures are published, standardised 
and validated for the population being assessed (i.e. 
reliability and validity data is available). 
2  Well covered                     
1  Adequately covered          
0  Poorly addressed               
CONFOUNDING 
1.14 
The main potential confounders are identified and 
taken into account in the design and analysis. 
2  Well covered                     
1  Adequately covered          
0  Poorly addressed               
STATISTICAL ANALYSIS 
1.15 The analysis conducted is appropriate to the design. 
2  Well covered                     
1  Adequately covered          
0  Poorly addressed               
1.16 Results are clearly reported 
2  Well covered                     
1  Adequately covered          
0  Poorly addressed               
1.17 
Confidence intervals, effect sizes, p-values etc. are 
provided where appropriate. 
2  Well covered                     
1  Adequately covered          
0  Poorly addressed               
  Quality scores 
 
                        Quality rating:    Good = >75% 
                                                      Acceptable = >50% 
                                                      Poor =  <50% 
 
Total score: _________(T possible = 34) 
 
Percentage: __________ 
 
Quality rating: _______ 
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Study 
Quality score 
(Total possible=34) 
Percentage Quality rating 
Burke et al., 1994 19 56% Acceptable 
Cunningham et al., 2007 28 82% Good 
De Boer et al., 2005 20 59% Acceptable 
Engstrom, 1992 27 79% Good 
Gold et al., 2000 29 85% Good 
Lindfred et al., 2008 26 76% Good 
Loonen et al., 2002 28 82% Good 
Mackner & Crandall, 2005 26 76% Good 
Marcus et al., 2009 29 85% Good 
Otley et al., 2006 26 76% Good 
Szajnberg et al., 1993 17 50% Acceptable 
Szigethy et al., 2004 28 82% Good 
APPENDIX 1.3 Quality rating of studies included in systematic review 
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APPENDIX 2.1 Instruction to authors Inflammatory Bowel Diseases 
 
Inflammatory Bowel Diseases 
PREPARATION OF MANUSCRIPT Manuscripts that do not adhere to the following 
instructions will be returned to the corresponding author for technical revision before 
undergoing peer review. (See specific guidelines for Letters to the Editor below.) For 
questions on preparing manuscripts for submission, please contact Julie Nash - 
nashj@hss.edu. 
 
Title Page Include on the title page (a) complete manuscript title; (b) authors' full names, 
highest academic degrees, and affiliations; (c) name and address for correspondence, 
including fax number, telephone number, and e-mail address; (d) address for reprints if 
different from that of corresponding author; and (e) sources of support that require 
acknowledgment. 
 
Structured Abstract and Key Words Limit the abstract to 250 words. It must be factual and 
comprehensive. Do not cite references in the abstract. Limit the use of abbreviations and 
acronyms, and avoid general statements (e.g., ``the significance of the results is discussed''). 
It should be sectioned into Background, Methods, Results, and Conclusions. List three to five 
key words. 
 
Text For full-length research articles, organize the manuscript in the following sequence: 
Abstract and Key Words, Introduction, Materials and Methods, Ethical Considerations, 
Results, Discussion, Acknowledgment, References, Tables, and Figure Legends. Original 
Research Articles: Authors are encouraged to submit articles in basic or clinical science. 
Review Articles of exceptional merit will also be accepted. Contributors should communicate 
with the Editors before submitting a review. Abbreviations must be defined at first mention in 
text and in each table and figure. If a brand name is cited, manufacturer and address (city and 
state/country) should be supplied. Acknowledge all forms of support, including 
pharmaceutical industry support, in an Acknowledgment paragraph. 
 
Abbreviations For a list of standard abbreviations, consult the Council of Biology Editors 
Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, 
MD 20814) or other standard sources. Write out the full term for each abbreviation at its first 
use unless it is a standard unit of measure. 
 
References The authors are responsible for the accuracy of the references. Key the references 
(double-spaced) at the end of the manuscript. Cite the references in text in the order of 
appearance. Cite unpublished data, such as papers submitted but not yet accepted for 
publication, personal communications, in parentheses in the text. If there are more than three 
authors, only name the first three authors and then use et al. For abbreviations of journal 
names, refer to List of Journals Indexed in Index Medicus. This can be accessed at 
http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below: 
Journal Article 1. Gudlaugsdottir S, van Dekken H, Stijnen T, et al. Prolonged use of proton 
pump inhibitors, CagA status, and the outcome of Helicobacter pylori gastritis. J Clin 
Gastroenterol. 2002;34:536-540. 
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Book Chapter 2. Tobin RW, Kimmey MB. Painful diseases of the gastrointestinal tract. In: 
Loeser JD, ed. Bonica's Management of Pain. 3rd ed. Philadelphia, PA: Lippincott Williams 
& Wilkins; 2001:1269-1292. 
 
Entire Book 3. Rohen JW, Yokochi C, Lütjen-Drecoll E. Color Atlas of Anatomy: A 
Photographic Study of the Human Body. 5th ed. Philadelphia, PA: Lippincott Williams & 
Wilkins; 2002. 
 
Software 4. Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control 
and Prevention; 1994. 
 
Online Journals 5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet 
Gynecol [serial online]. January 1988;71:22-37. Available from: BRS Information 
Technologies, McLean, VA. Accessed December 15, 1990. 
Database 6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 
1996. Updated March 29, 1996. 
 
World Wide Web 7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS Web site]. June 
1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997. 
 
Figures Art should be created/scanned and saved and submitted as either a TIFF (tagged 
image file format), or an EPS (encapsulated postscript) file. Line art must have a resolution of 
at least 1200 dpi (dots per inch), and electronic photographsMradiographs, CT scans, and so 
onMand scanned images must have a resolution of at least 300 dpi. If fonts are used in the 
artwork, they must be converted to paths or outlines or they must be embedded in the files. 
Color images must be created/scanned and saved and submitted as CMYK files. Please note 
that artwork generated from office suite programs such as Corel Draw and MS Word and 
artwork downloaded from the Internet (JPEG or GIF files) cannot be used. Cite figures 
consecutively on the site, and number them in the order in which they are discussed. 
 
Figure Legends Legends must be submitted for all figures. They should be brief and specific, 
and they should appear after the text and before the references. Use scale markers in the 
image for electron micrographs, and indicate the type of stain used. 
 
Color Figures The journal accepts for publication color figures that will enhance the article, 
and at the discretion of the Editors, figures may be printed in color for no additional charge. 
Otherwise, authors who submit color figures will receive an estimate of the cost for color 
reproduction. Figures are published online in color at no additional cost. 
 
Tables Create tables using the table creating and editing feature of your word processing 
software (e.g., Word). Do not use Excel or comparable spreadsheet programs. Submit all 
tables as separate files. Cite tables consecutively in the text, and number them in that order. 
Key each on a separate sheet, and include the table title, appropriate column heads, and 
explanatory legends (including definitions of any abbreviations used). Do not imbed tables 
within the body of the manuscript. They should be self-explanatory and should supplement, 
rather than duplicate, the material in the text. 
 
Style Follow American Medical Association Manual of Style (9th edition). Stedman's 
Medical Dictionary (27th edition) and Merriam Webster's Collegiate Dictionary (10th 
edition) should be used as standard references. Refer to drugs and therapeutic agents by their 
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accepted generic or chemical names, and do not abbreviate them. Use code numbers only 
when a generic name is not yet available. In that case, supply the chemical name and a figure 
giving the chemical structure of the drug. Capitalize the trade names of drugs and place them 
in parentheses after the generic names. To comply with trademark law, include the name and 
location (city and state in USA; city and country outside USA) of the manufacturer of any 
drugs, supplies, or equipment mentioned in the manuscript. Use the metric system to express 
units of measure and degrees Celsius to express temperatures, and use SI units rather than 
conventional units. 
 
 
Publisher's Contact - Journal Production 
Return corrected page proofs, and any other related materials to: 
Jessica Rodwick 
John Wiley & Sons, Inc. 
Email: ibdprod@wiley.com 
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From: Theron, Kirsty 
Sent: 13 January 2010 11:58 
To: 'SARAH CATHERINE ROSS' 
Cc: Barber, Michael; Russell, Richard (NHSmail) 
Subject: Substantial Amendment - R&D Ref GN09GA437 Protocol No 6 Substantial Amendment 1 10 
November 2009 -cc: Sarah Ross 
 
Dear Dr Richard Russell, 
 R&D Ref: GN09GA437   Ethics Ref: 09/S1001/54 
Investigator: Dr Richard Russell 
Project Title: The impact of Inflammatory Bowel Disease on psychosocial functioning in early, mid 
and late adolescence 
Protocol Number: Version 6 
Amendment: Substantial Amendment 1 10 November 2009 
Sponsor:  
 I am pleased to inform you that R&D have reviewed the above study's Amendment 1 (10/11/09) and 
can confirm that Management Approval is still valid for this study. 
 I wish you every success with this research project. 
 Yours sincerely, 
  
 Dr Michael Barber (PhD) 
Research and Development Central Office 
NHS Greater Glasgow and Clyde 
Western Infirmary 
38 Church Street 
Glasgow, G11 6NT 
 tel: 0141-211-8548 or 5 8548 (internal) 
mailto:michael.barber@ggc.scot.nhs.uk 
Appendix 2.5 Email of R&D approval for amendment 
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A Comparison of Psychosocial Functioning between Early, Mid and 
Late Adolescence in Young People with Inflammatory Bowel 
Disease. 
 
Information Sheet – Young person 
 
We would like to invite you to take part in a research project. Before you decide 
you need to understand why the research is being done and what you would be 
asked to do. Please take time to read the following information carefully. You 
can talk to others about this project if you wish. You can also ask us if there is 
anything that is not clear or if you would like more information.  
 
Who is carrying out this project? 
This project is being carried out by Sarah Ross, Trainee Clinical Psychologist, 
from the Department of Psychological Medicine, University of Glasgow together 
with the department of Gastroenterology at Yorkhill.   
 
Why are we doing this project? 
This project is going to look at how Inflammatory Bowel Disease (or IBD) like 
Crohn‟s Disease or Ulcerative Colitis affects young people throughout their 
teenage years. We want to find out: 
 How IBD makes teenagers feel about their body and appearance.  
 How IBD makes you feel generally, and what effect it has on getting 
along with others.  
 Whether people of different ages cope in different ways after they are 
told they have IBD. 
 We are also interested in whether the length of time young people have 
been ill makes a difference to how they feel about themselves.  
 
Finding out whether young people at certain ages are more likely to have 
problems, means that we can give those people more help in the future.  
 
APPENDIX 2.6 
Information sheet for young people - clinic version  
(1 of 4 versions: parent - clinic version; young person - postal version; parent - postal version) 
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Why have I been invited to take part in this project? 
You have been invited to take part in this project as you have Inflammatory 
Bowel Disease (or IBD) like Crohn‟s Disease or Ulcerative Colitis and are a young 
person. 
 
Do I have to take part? 
No, it is up to you to decide. We will describe the project to you and go through 
this information sheet. You will be asked to sign a form to show you have agreed 
to take part. You are free to stop taking part at any time, without giving a 
reason. This would not affect the care you receive or your future treatment.  
 
What does taking part involve? 
The main researcher (Sarah) will talk to you and your parent while you are 
waiting for your clinic appointment at the hospital. She will give you another 
copy of this information sheet and go through this with you and your parent. You 
will have the chance to ask any questions. If you would like to take part in the 
project, Sarah (the person carrying out the research) will ask you to sign a form 
to show you understand what the project is about and that you want to take 
part. If you are under 12 years old, your parent will also be asked to sign a form. 
 
After this, you will go to a free clinic room with Sarah and spend around 20 
minutes completing 5 short questionnaires. 
 
If you agree, Sarah will gather some more information about you from your 
medical file once you have gone.  
 
What happens to the information? 
All your information and personal details will be kept completely private, and 
known only to Sarah. We will keep the information safely and cannot show it to 
other people, without you agreeing to this.  
 
What are the possible benefits of taking part? 
It is hoped that by taking part in this project, you will be helping us understand 
how living with Inflammatory Bowel Disease (IBD) affects how young people feel 
about themselves and how they cope with their everyday lives. This will help us 
to plan our service so that we can help teenagers with IBD better in the future. 
As a thank you for taking part we will give you a £10 gift voucher. 
 
Who has reviewed the project? 
This project has been reviewed by the West of Scotland Research Ethics 
Committee.  
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If you have any further questions? 
We will give you a copy of the information sheet and signed consent (agreement) 
form to keep. If you would like more information about the project and wish to 
speak to someone not closely linked to the project, please contact Vikki Garrick 
(0141 201 9247). 
 
Contacts: 
Sarah Ross (Main Researcher), Trainee Clinical Psychologist    
Section of Psychological Medicine, Gartnavel Royal Hospital, 1055 Great 
Western Road, Glasgow, G12 0XH 
01294 323560       or      s.ross.2@research.gla.ac.uk 
 
Vikki Garrick, Paediatric Inflammatory Bowel Disease Nurse Specialist 
The Royal Hospital for Sick Children, Dalnair Street 
Glasgow, G3 8SJ   Tel: 0141 201 9247 
 
If you have a complaint about any aspect of the project? 
If you are unhappy about any part of the project and wish to make a complaint, 
please contact Sarah first. You can also make a complaint through normal NHS 
complaint pathways.  
 
 
 
Thank-you for your time and help! 
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Subject number: 
 
 
A Comparison of Psychosocial Functioning between Early, Mid and Late 
Adolescence in Young People with Inflammatory Bowel Disease. 
 
Consent Form 
 
Please initial each BOX to indicate agreement     Please initial box 
 
 
I have read and understand the information sheet dated 07/09/2009 (version 3) that explains 
what this project is about and have had the chance to ask questions. 
 
 
I understand that taking part in this project is my choice and that I can decide not to take 
 part at any time.  
 
 
I agree to the person carrying out the project looking at some parts of my medical notes.  
 
 
 
I agree to take part in the above project. 
 
 
 
---------------------------------------               -----------------         ---------------------------------- 
Name of Participant           Date      Signature 
 
 
 
---------------------------------------               -----------------          --------------------------------- 
Name of Researcher           Date       Signature 
 
 
 
1 copy to the participant, 1 copy to the researcher, 1 original copy for the participant’s 
notes 
 
APPENDIX 2.7 
Consent form for young people (if under 12 parents signed a similar consent form as well) 
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The Royal Children‟s Hospital,          
Yorkhill, Dalnair Street 
Glasgow, G3 8SJ  
 
Date: 
 
Dear Parent/Guardian 
 
A Comparison of Psychosocial Functioning between Early, Mid and Late 
Adolescence in Young People with Inflammatory Bowel Disease. 
 
We are writing to ask whether you would be willing for .............................................. 
to take part in a research project.  We want to find out how Inflammatory 
Bowel Disease (IBD) affects young people throughout their adolescence.  We 
want to look at how IBD may impact on relationships, how adolescents feel about 
their body and appearance, and about themselves more generally.  
 
The study is to be conducted by Sarah Ross (Trainee Clinical Psychologist) in 
the Gastroenterology Outpatient clinic at the Children‟s Hospital (Yorkhill). If 
you agree to your child taking part in this study, your child will be asked to 
spend a maximum of 20 minutes filling in some questionnaires in a spare clinic 
room while waiting for their routine outpatient appointment.  
 
We have enclosed two short information sheets to give you and your child an 
idea of what is involved in this study. There are also two consent forms for your 
information. If you have any questions please contact Sarah Ross 
(07833095377) or, for someone not closely connected with the study, Vikki 
Garrick (0141 201 9247).  
 
Yours sincerely, 
 
 
 
Sarah Ross      Dr Richard Russell 
Trainee Clinical Psychologist  Consultant Paediatric Gastroenterologist 
APPENDIX 2.8 
Covering letter sent to all participants 
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Instruction sheet for filling in questionnaires 
 
Thank you for agreeing to take part in the study. Please fill in the 5 
questionnaires in the order below, making sure you don‟t miss any out. Remember 
you can phone Sarah (the main researcher) if you are not sure about any of the 
questions or how to answer them. You can also get help from your parents, but 
remember we are interested in what you think.  
 
Please fill the questionnaires in this order – it takes around 20 minutes. 
 
(1) Questionnaire 1 - “Demographic Questionnaire” 
Please just answer these 4 questions. 
 
(2) Questionnaire 2 –  “Youth Self-Report for ages 11-18” 
Don‟t worry about filling in the crossed out part at the top. Please 
start at Question 1 – remember to look at the questions on the right 
hand side of the page (“compared to others of your age, about how 
much time do you spend in each?”). There are 2 sides.  
 
On the other page put a circle around the number you think describes 
you. For example: for Question 1, if you think compared to other 
healthy young people your age your social life is the same, you circle 
number 2.  
 
(3) Questionnaire 3 - “Body Esteem Scale for Adolescents & 
Adults” 
Please circle the number to show how often you agree with the 
statements. For example: for Question 1, if you sometimes like what 
you look like in pictures, you would circle number 2 as it is in the 
„sometimes‟ column. There are 2 pages (23 questions).  
 
(4) Questionnaires 4 – “Rosenberg Self-Esteem Scale” 
Please circle SA, A, D or SD depending on how much you agree with 
the statements. For example for Question 1, if you strongly agree with 
the statement “On the whole, I am satisfied with myself”, you would 
circle SA. If you disagree, you would circle D.  
 
 
APPENDIX 2.9 
Sent to those completing questionnaires at home (postal version) 
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(5) Questionnaires 5 - “Hospital Anxiety & Depression Scale” 
Please underline or circle the reply that describes how you have been 
feeling over the last week. For example: if you feel “tense or „wound 
up‟” from time to time, occasionally – underline or circle this on the 
form. If you never feel tense or „wound up‟ you would circle „not at all‟. 
Just ignore the bit down the left hand side of the page. There are 3 
pages. 
 
 
Thank you for filling in all the questionnaires. So we can send you your £10 
Amazon gift voucher please put your email address on the sheet provided and 
post it back with your consent form in envelope A. 
 
 
We realise that some of the questions may have made you think about things 
like friendships and how you feel about yourself. If you have found this a bit 
upsetting and want to talk about it, please either talk to your parent or you can 
phone Sarah (the main researcher) on 01294323552. Thank you again.  
 
 
Don’t forget to put your consent form in envelope A and the questionnaires 
in envelope B and send them back to the hospital. 
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APPENDIX 2.10  
 
 
Body-Esteem Scale for Adolescents and Adults 
Beverley K. Mendelson, Donna R. White, and Morton J. Mendelson 
 
Indicate how often you agree with the following statements ranging from "never" (0) to "always" (4).  
Circle the appropriate number beside each statement. 
   
Never 
 
Seldom 
Some-
times 
 
Often 
 
Always 
1. I like what I look like in pictures. 0 1 2 3 4 
2. Other people consider me good looking. 0 1 2 3 4 
3. I'm proud of my body. 0 1 2 3 4 
4. I am preoccupied with trying to change my body 
weight. 
0 1 2 3 4 
5. I think my appearance would help me get a job. 0 1 2 3 4 
6. I like what I see when I look in the mirror. 0 1 2 3 4 
7.  There are lots of things I'd change about my looks if I 
could. 
0 1 2 3 4 
8.   I am satisfied with my weight. 0 1 2 3 4 
9. I wish I looked better. 0 1 2 3 4 
10. I really like what I weigh. 0 1 2 3 4 
11. I wish I looked like someone else. 0 1 2 3 4 
12. People my own age like my looks. 0 1 2 3 4 
13. My looks upset me. 0 1 2 3 4 
14. I'm as nice looking as most people. 0 1 2 3 4 
15. I'm pretty happy about the way I look. 0 1 2 3 4 
16. I feel I weigh the right amount for my height. 0 1 2 3 4 
17. I feel ashamed of how I look. 0 1 2 3 4 
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18. Weighing myself depresses me. 0 1 2 3 4 
19. My weight makes me unhappy 0 1 2 3 4 
20. My looks help me to get dates. 0 1 2 3 4 
21. I worry about the way I look. 0 1 2 3 4 
22. I think I have a good body. 0 1 2 3 4 
23. I'm looking as nice as I'd like to. 0 1 2 3 4 
 
Three subscales: BE-Appearance (1, 6, 7*, 9*, 11*, 13*, 15, 17*, 21*, 23); BE-Weight (3, 4*, 8, 10, 
16, 18*, 19*, 22); and BE-Attribution (2, 5, 12, 14, 20).  [* negative items, which must be recoded for 
scoring by reversing the scale (i.e., 0 = 4, 1 = 3, 2 = 2, 3 = 1, 4 = 0).] 
 
Address correspondence, including requests for a copy of the manual for the Body-Esteem Scale for 
Adolescents and Adults, to Dr. Beverley K. Mendelson at <bev@ego.psych.mcgill.ca>. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
106 
 
APPENDIX 2.11 
 
Demographic Questionnaire 
Study Number: 
(1) How old are you? ____________________ 
 
(2) Please circle your gender            female                 male 
 
(3) What is your post code? __________________  
 
If you don‟t know your post-code, please write your address and we can 
look it up 
_______________________________________________ 
 
(4) Please circle the option that best describes your family 
 
I live with my mum and dad 
I live with my mum 
I live with my dad 
I live with my mum and stepfather/mum‟s boyfriend 
I live with my dad and stepmother/dad‟s girlfriend 
I live with my grandparents 
Other (please explain) ____________________________ 
_____________________________________________ 
 
      (b)  How many brothers and sisters do you have? ____________ 
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Table a: Multiple regression for predictors and outcome self-esteem 
Model  SE   t Sig. 
(Constant) 22.38 1.90  11.81 0.00 
Gender -4.39 1.53 -0.37 -2.87 0.01* 
Early-mid adolescence -1.28 1.70 -0.11 -0.75 0.46 
Early-late adolescence -0.95 2.20 -0.06 -0.43 0.67 
SES 0.00 0.00 0.19 1.48 0.15 
Disease type (UC/CD) -1.85 1.84 -0.13 -1.01 0.32 
Note: R
2 
= 0.189,  p=0.06 ns      *p>0.01 
 
Table b: Multiple regression for predictors and outcome social functioning 
 
Model  SE   t Sig. 
(Constant) 21.19 1.51  13.08 0.00 
Gender -2.10 1.18 -0.25 -1.78 0.08 
Early-mid adolescence -1.76 1.28 -0.21 -1.37 0.18 
Early-late adolescence -2.36 1.77 -0.20 -1.34 0.19 
SES 0.00 0.00 0.11 0.77 0.45 
Disease type (UC/CD) -1.54 1.40 -0.15 -1.10 0.28 
Note: R
2 
= 0.14,  p=0.22 ns                   
 
Table c: Mean total scores and scores for subscales on measures of psychosocial functioning. 
 
Measure Early (11-13yrs) Mid (14-15yrs) Late (16-18yrs) 
Mean SD Mean SD Mean SD 
YSR 
Activities scale 
Social scale 
Academic scale 
Total score 
T score 
 
9.09 
8.90 
2.15 
20.14 
44.16 
 
2.41 
2.48 
0.43 
4.09 
9.91 
 
8.05 
8.06 
2.18 
18.29 
39.75 
 
2.63 
2.29 
0.57 
4.47 
10.17 
 
8.53 
8.17 
2.30 
18.99 
41.22 
 
2.60 
2.88 
0.49 
4.58 
10.88 
RBES 
BE-Appearance 
BE-Weight 
BE-Attitudes 
BE-Total 
 
26.60 
19.92 
9.68 
55.89 
 
8.62 
8.46 
3.79 
17.59 
 
26.17 
21.00 
8.96 
55.68 
 
10.79 
8.26 
2.97 
17.50 
 
24.78 
19.22 
9.89 
53.91 
 
8.93 
10.70 
3.69 
24.47 
RSES 21.36 4.91 20.29 6.17 21.78 6.70 
HADS 
HADS- Depression 
HADS – Anxiety 
 
2.33 
6.19 
 
2.62 
4.51 
 
2.40 
6.52 
 
2.31 
3.92 
 
4.18 
7.82 
 
3.84 
5.33 
 
APPENDIX 2.12 
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ABSTRACT 
Background: The onset of Inflammatory Bowel Disease (IBD) is highest during adolescence, 
when young people are endeavouring to establish an identity, develop peer and romantic 
relationships and become autonomous.  The symptoms of IBD may make it more difficult for 
them to make these essential developmental transitions and cause difficulties in psychosocial 
functioning. While previous research has compared adolescents with IBD to healthy controls, 
it may be more informative to take a developmental approach, examining psychosocial 
functioning within the early, mid and late stages of adolescence.  
Aims: The primary aim of this study is to investigate whether stage of adolescence has an 
effect on social functioning, body image and self-esteem in adolescents with IBD. The 
secondary aims are to determine whether stage of adolescence has an effect on coping post 
diagnosis, and whether time since diagnosis and disease phenotype have an effect on outcome 
measures. 
Methods: 105 adolescents aged between 11 and 18 years with IBD will be recruited from a 
gastroenterology outpatient clinic. Each adolescent will complete measures of social 
functioning, body image, self-esteem and mood. Demographic and disease information will 
also be gathered. Outcome measures will be compared between the three groups (early, mid 
and late adolescence). 
Applications: Determining whether a particular sub-group of adolescents are more at risk for 
developing difficulties would allow early intervention of targeted interventions to prevent 
difficulties becoming entrenched. Additionally, this study may pave the way for other 
research examining psychosocial functioning within a developmental context. 
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1. Introduction 
Inflammatory Bowel Disease (IBD) is caused by chronic inflammation of the 
gastrointestinal tract and comprises of three main disorders; Crohn‘s disease (CD), 
ulcerative colitis (UC) and intermediate colitis (IC). These result in ongoing or 
recurring symptoms including frequent diarrhoea, abdominal pain, fatigue, perianal 
disease, poor appetite, delayed puberty, weight loss, nausea and growth delay. The 
onset of IBD within childhood years is reported to be highest in adolescence 
(Sawczenko et al., 2001).  
 
During adolescence, there are a number of biological, psychological and social 
changes that may make coping with a chronic disease more challenging (Suris et al., 
2004). From a psychosocial perspective the tasks of adolescence are to establish an 
identity, develop peer and romantic relationships and establish greater independence 
and autonomy (Erikson, 1956). Adolescence can be considered as consisting of three 
developmental stages; early (11 to 13), middle (14 to 15) and late (16 to 18 years old), 
although some degree of overlap is inevitable (Berk, 2007). Early adolescence can be 
characterised by the tremendous assimilation of new experiences; including the 
physical changes of puberty and social changes such as moving to senior school. This 
introduces a new set of demands requiring more sophisticated social and cognitive 
skills. Conflict between young people and their parents tends to increase at the start of 
puberty, while greater importance is placed on friendships and being part of the 
crowd.  
 
In mid adolescence there is a peak in the preoccupation with other‘s view of self 
(Elkind & Bowen, 1979) and consequently the peer group is considered very 
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influential. Self-esteem, which can be defined as the discrepancy between one‘s ideal 
self and what one perceives to be one‘s real self (Harter, 1990) has been shown to dip 
in early to mid adolescence (Seidman et al., 1994). At this stage young people are 
often concerned with establishing their independence and autonomy, tending to spend 
more time with their friends, or alone, than with their parents.   
 
In late adolescence rising levels of self-esteem (Harter, 1990) are accompanied by 
decreasing levels of family conflict. Some young people may have developed formal 
operational cognitive skills (Piaget, 1952) and be able to solve abstract problems. One 
of the key tasks of this stage is forming emotionally intimate partnerships, and 
beginning to develop a clear self-identity. At this stage adolescents may be more 
future oriented, thinking in terms of further education, jobs and life goals.   
 
The symptoms associated with IBD can make it more difficult for adolescents to 
complete the essential developmental transitions outlined above. During a ‗flare up‘ 
when the disease is active, adolescents with IBD may need to spend a great deal of 
time in the bathroom and fear becoming a target of ‗bathroom humour‘.  The 
perceived need to be near a bathroom at all times may also limit social activities. 
Adolescents are likely to miss considerable time off school due to illness and hospital 
appointments, impacting on both academic work and peer relationships. 
 
There have been mixed outcomes of studies examining social functioning in young 
people with IBD. Studies using self-report norm-referenced measures of social 
competence found mean scores in the average range (Gold et al., 2000; Mackner & 
Crandall, 2005). Whilst studies using comparison groups and parent-report measures, 
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found lower social competence scores in children and adolescents with IBD than in 
healthy comparison groups (Engstrom, 1999; Mackner & Crandall, 2006). A recent 
study reported that a diagnosis of IBD in adolescence, as supposed to in childhood, 
was associated with greater difficulties in social functioning (Mackner & Crandall, 
2006). 
 
Some adolescents with IBD will undergo surgery or have a colostomy bag which can 
lead to reluctance to engage in peer or intimate relationships, as well as having an 
impact on body image. Delayed puberty and slowed growth, as well as side effects 
from steroids, such as weight gain or facial changes, may also impact on body image 
and self-esteem. There has been little research to date on the impact of IBD on body 
image, although population based studies show that adolescents with a chronic illness 
report higher body dissatisfaction than healthy adolescents (Neumark-Sztainer et al., 
1995). Loonen and colleagues (2002) found adolescents with IBD had significantly 
lowered scores on the body complaints domain of a health-related quality of life 
(HRQOL) measure. Conversely, a more recent study using a norm-based scale to 
assess feelings about physical appearance found mean scores in the average range, 
and no difference between young people with IBD and healthy controls (Mackner & 
Crandall, 2005). It should be noted, however, that to the author‘s knowledge no 
specific measures of body image have been administered to adolescents with IBD.  
 
Studies examining self-esteem in this population using norm-based questionnaires 
report mean scores in the average range (Gold et al., 2000; Mackner & Crandall, 
2005; De Boer, 2005) and comparable levels of self-esteem to healthy adolescent 
controls (Lindfred et al., 2008). However, other studies using comparison groups, 
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found that children and adolescents with IBD had significantly lower self-esteem than 
healthy controls (Engstrom, 1999; Mackner & Crandall, 2005).  
 
While relatively little research has examined the areas mentioned above, more work 
has investigated the prevalence of mood disorders in this population. A recent review 
concluded that young people with IBD were more likely to meet criteria for anxiety or 
depression than healthy peers, but that rates of mood disorder were similar to those 
associated with other chronic illnesses (Mackner, Crandall & Szigethy, 2006). 
Research examining depression in the general population, suggests adolescents who 
have completed puberty have significantly higher rates of depression than their pre-
pubertal peers (Lewinsohn et al., 1994). Therefore it may be expected that older, post-
pubertal adolescents with IBD will experience more difficulties with mood.  
 
It is difficult to determine the validity of previous studies and to make comparisons 
between them due to a number of methodological difficulties such as varying 
measures, small sample sizes and large age ranges. Recently, several studies have 
used health-related quality of life (HRQOL), encompassing physical, social and 
psychological functioning, as a primary outcome measure. It is possible that more 
subtle differences in specific areas of functioning may be missed by such broad 
measures. 
 
This is a complex population with a number of factors that may be impacting on 
psychosocial functioning such as gender, time since diagnosis, disease type and 
severity and age. Most studies of adolescents with IBD have found gender to be 
negatively associated with HRQOL, with girls scoring lower than boys (Loonen, 
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2004). However, others have found no sex differences for HRQOL (Otley et al., 
2006) or self-esteem (Lindfred et al., 2008). In the adult IBD literature, females have 
been found to have lower HRQOL than males (e.g. Rubin et al., 2004).  
 
While HRQOL has been found to significantly improve in the first six months post 
diagnosis and then continue to improve throughout the first year (Otley et al., 2006), 
further information on more long term functioning is not available. Disease type may 
have an impact on psychosocial functioning. The adult literature suggests patients 
with CD have reduced HRQOL compared to those with UC (e.g. Nordin et al., 2002). 
Loonen and colleagues (2002) reported that young people with CD had lower 
HRQOL scores than those with UC, although these differences were not significant. 
CD has been found to have a greater impact on social functioning than UC in one 
study (Ferry, 1999) although other researchers have found no difference (Lindfred et 
al., 2008, Mackner & Crandall, 2005). 
 
Recently, increasing age has been shown to be associated with a decrease in HRQOL 
(Otley et al., 2006) and self-esteem (Lindred et al., 2008) in adolescents with IBD. 
Similar findings have been reported in other paediatric chronic illnesses. It has been 
suggested that this could be the result of the adolescent‘s increasing cognitive ability 
to appreciate the long-term implications of his or her illness, in addition to the effects 
of IBD on their attainment of key developmental tasks, such as identity development 
and establishing autonomy (Loonen et al., 2002).  
 
While research has started to examine the psychosocial sequelae of IBD in 
adolescents, it has primarily focussed on making comparisons between adolescents 
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with IBD and their healthy peers. Adolescence is a time of transition, with a huge 
degree of heterogeneity within the 11 to 18 age group, making it questionable whether 
examining this population as one group is useful. It may be more valuable to consider 
the effects of IBD within a developmental context, comparing psychosocial 
functioning in early, mid and late adolescence in order to determine if one of these 
sub-groups is at a greater risk.  
 
It is possible that while adolescents with IBD, as a group, have comparable self-
esteem to their healthy peers, there may be subsets that have significantly lowered 
self-esteem. Lindfred and colleagues (2008) found that severity of disease, being 
female and being in mid adolescence increased the risk of low self-esteem in 
adolescents with IBD. Research has shown that lowered self-esteem, body 
dissatisfaction and impaired social functioning can be risk factors for later depression 
and anxiety (Carr, 1999). Therefore gaining a detailed picture of this population 
would have important service implications, allowing input to be directed to the most 
vulnerable group.  
 
2. Aims and hypotheses 
Primary aim: 
To investigate the impact of IBD on social functioning, body-image and self-esteem 
in early, mid and late adolescence. 
 
Research questions:  
1. Does stage of adolescence have an effect on social functioning, body image and 
self-esteem in adolescents with IBD? 
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2. Does stage of adolescence have an effect on mood (specifically anxiety and 
depression), and does mood correlate with social functioning, body image and 
self-esteem in adolescents with IBD? 
3. Within each stage of adolescence, does length of time since diagnosis have an 
effect on social functioning, body image and self-esteem in adolescents with IBD? 
4. To explore whether type of disease (CD, UC or IC) has an effect on social 
functioning, body image and self-esteem in adolescents with IBD (subject to 
numbers achieved for each group)? 
 
Due to the limited relevant research, the following tentative hypotheses are proposed: 
1. Younger adolescents will report less impairment in the areas of social functioning, 
body image and self-esteem than older adolescents. 
2. Younger adolescents will report fewer symptoms of anxiety and depression than 
older adolescents. 
3. Adolescents with CD will report greater impairment in the areas of social 
functioning, body image and self-esteem than adolescents with UC or IC. 
 
3. Plan of investigation 
Participants 
Adolescents attending the Gastroenterology outpatient clinic at The Royal Hospital 
for Sick Children, Yorkhill. According to clinical staff, around 170 adolescents attend 
the clinic each year.  
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Inclusion and exclusion criteria 
Participants must be aged between 11-18 years old, attending senior school, and have 
a diagnosis of UC, CD or IC. They must be more than six months post-diagnosis in 
order that the initial shock has reduced and some adjustment has occurred. 
Participants will be excluded who have a serious comorbid medical condition, a major 
psychiatric diagnosis or who have a level of impaired cognitive functioning which 
would prevent them from being able to give informed consent or complete the 
questionnaires.  
 
Recruitment procedures 
Letters containing information about the study will be sent to all adolescents due to 
attend the outpatient clinic and who fulfil inclusion criteria. Letters will be co-signed 
by the Consultant Paediatrician in order to encourage participation.  Adolescents will 
be approached at outpatient clinic appointments, given further information about the 
study and invited to participate. Informed consent will be sought from both the 
adolescent and their parent. It will be explained that choosing not to take part in the 
study will not adversely affect their medical treatment. Confidentiality and data-
protection procedures will be made clear.  
 
Measures 
1. The Rosenberg Self Esteem Scale (RSES) (Rosenberg, 1965) 
This is a widely used and well validated brief (10 item) measure of global self 
esteem for use with adolescents. Participants indicate the extent to which they 
agree with statements (e.g. ―On the whole, I am satisfied with myself‖) on a four 
point scale. The RSES takes less than five minutes to complete.  
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2. Social competence scale of The Youth Self Report checklist (YSR) 
(Achenbach, 1991) 
This is one of the most widely used standardised assessments for measuring social 
competence in adolescents. The self-report social competence scale measures the 
young person‘s participation in hobbies, games, sports, chores, friendships and 
activities and takes around five minutes to complete. The YSR has adequate 
psychometric properties (Achenbach, 1991). Additionally, there will be two 
questions using a Likert scale in order to gather information on the young person‘s 
perception of their social life compared to their healthy peers, and the extent to 
which this is affected by IBD (see Appendix A
5
). 
 
3. Revised Body-Esteem Scale (Mendelson & White, 1993) 
This measures adolescents‘ attitudes and feelings about their body and 
appearance. There are three subscales: general feelings about appearance, weight 
satisfaction, and evaluations attributed to others about one‘s body and appearance. 
Respondents indicate their degree of agreement with 23 statements (e.g. ―I like what I 
look like in pictures‖) using a five-point scale (see Appendix Bi). This takes around 
five minutes to complete and has been shown to be valid and reliable in a wide 
age range (Mendelson, Mendelson & White, 2001).  
 
4. Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983)  
This is a brief 14 item self-report measure developed for use with adult medical 
out-patients. However, construct and concurrent validity have now been  
                                                          
5
 Please note that due to space constraints original Appendices have not been included 
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demonstrated in physically ill adolescents (aged 12-17) (White et al., 1999). The 
questionnaire has two subscales, one for depression and one for anxiety and takes 
around two to three minutes to complete. A possible limitation will be the use of 
the HADS with 11 year olds in this study. However, by including only 11 year 
olds that have entered senior school, participants should have adequate cognitive 
skills to complete this measure. 
Demographic information including age, gender, socio-economic status (by post 
code) and family composition will be collected via a brief (four item) questionnaire 
given to adolescents. Disease information, including current disease severity will be 
measured using the Pediatric Crohn‘s Disease Activity Index (PCDAI; Hyams et al., 
1991) and the Pediatric Ulcerative Colitis Activity Index (PUCAI; Turner, 2008). The 
PCDAI and PUCAI have good reliability and validity and are collected routinely by 
the clinical team. Additionally, information on length of time in hospital, disease 
duration, current medication, pubertal status and whether the adolescent has 
undergone resectional or non-resectional surgery will be gathered from patient files.  
 
Design  
This study uses a cross-sectional between groups design to compare psychosocial 
functioning in early, mid and late adolescence.  
  
 Research procedures  
After gaining consent, participants will be asked to complete the questionnaires in a 
clinic room. This should take no more than 20 minutes. The main researcher will be 
present during this time in order to answer any questions and provide assistance in 
completing questionnaires. Questionnaires will be marked and entered into an SPSS 
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database where participants will only be identifiable by the number and letter 
sequence given to them when they attended clinic. 
 
 Justification of sample size 
Although previous studies have looked at psychosocial functioning in adolescents 
with IBD as a whole; no studies have been identified which look at differences 
between stages of adolescence, and in this regard the study is exploratory. Studies 
comparing psychosocial functioning and HRQOL in adolescents with IBD to healthy 
controls have reported medium effect sizes (Mackner & Crandall, 2006; Loonen et al., 
2002; De Boer et al., 2005). These papers provide the best available indication of 
likely effect size.  
 
Therefore, in order to calculate sample size (N) the following assumptions were 
made: significance criterion (alpha) was taken to be 0.05, effect size to be medium    
(f = 0.25 according to Cohen, 1988) giving power of 0.8 if N=159 (53 per group). 
This was calculated using an online power calculator (G*power, Faul et al., 2007). 
However, information from the research site regarding the number of possible 
participants in the available time period, indicated a maximum of 100-110 young 
people as a realistic target. Thus, with 35 participants per group (N=105); a medium 
effect size (f = 0.25) and significance criterion of 0.05, this study would have power 
of 0.6. As aspects of this study are exploratory, it will be important to calculate effect 
sizes from our data, so that future studies can use this as a basis for their research.  
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 Settings and equipment 
The setting for the study is the Royal Hospital for Sick Children, Yorkhill NHS Trust, 
Glasgow. Questionnaires will be administered in a free clinic room at the 
Gastroenterology outpatient clinic.  
 
 Data Analysis 
Outcome measures (self-esteem, body-image, social functioning, anxiety and 
depression scores) will be compared between the three groups (early, mid and late) 
using ANOVA if data is normally distributed and a non-parametric alternative if data 
is non-normally distributed. If data suggest these will be informative, some more 
complex statistical procedures such as multiple regression will be employed.  
 
4. Health and Safety  – researcher and participant safety issues 
No health and safety issues are anticipated. Questionnaires will be completed in the 
hospital clinic where, if any medical problems arise, medical staff will be on hand. 
 
5. Ethical issues 
Ethical approval will be sought from the Greater Glasgow NHS Trust Ethics 
Committee as well as the local Research and Development department at Yorkhill 
hospital. This is a study recruiting young people, so care must be taken to provide 
information about the study in a developmentally appropriate manner. Informed 
consent will be sought from both the young person and their parent (even if the young 
person is over 16). Consideration will be taken if young people are feeling unwell or 
in pain due to flare ups.  
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If psychological difficulties are picked up, this information will be fed back to the 
young person and their parent. They will then have the option of requesting a referral 
to the dedicated psychology service attached to the Gastroenterology team. Feedback 
about the study in general may be given to participants who attend the annual IBD 
information day in the form of a presentation summarising the results of the study. 
 
6. Financial issues  
While the authors of the RSES, BES and HADS indicate permission for unlimited 
photocopying of these forms, the greatest expenditure will be purchasing forms for 
the YSR. The YSR is the quickest and most reliable questionnaire measuring social 
functioning in this age group. Furthermore, the YSR has been successfully used to 
examine social functioning in adolescents with IBD in previous studies (e.g. Mackner 
and Crandall, 2005). Additionally there will be the cost of sending letters to 
participants and photocopying information sheets, consent/assent forms and the 
reproducible questionnaires. 
 
7. Timetable 
Submission of proposal for ethical approval – July 2009 
Preparation of materials for research – September 2009 
Data collection – October 2009 – April 2010 
Data analysis and write up – April 2010 – June 2010 
Final draft to supervisor – June 2010 
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8. Practical application 
The Gastroenterology team at Yorkhill hospital are currently developing their service 
and are supportive of this research. They would be able to use the findings of this 
study in order to direct existing resources into the most clinically appropriate areas 
and potentially gain more funding for psychology input.  
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